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Background 
Starting in 1999, the National Health 
and Nutrition Examination Survey 
(NHANES) became a continuous, 
ongoing annual survey of the 
noninstitutionalized civilian resident 
population of the United States. A 
continuous survey allowed content to 
change to meet emerging needs. 
Objective 
This report describes how NHANES 
for 1999–2010 was designed and 
implemented. NHANES is a national 
survey designed to provide national 
estimates on various health-related 
topics. 
Methods 
The survey used in-person 
face-to-face interviews and physical 
examinations for data collection. 
Approximately 5,000 people per year 
participated in NHANES. The 5,000 
people surveyed each year are 
representative of the entire U.S. 
population. 
Keywords: survey design • mobile 
examination center • field operations 
• NHANES National Health and Nutrition 
Examination Survey: Plan and 
Operations, 1999–2010 
by George Zipf, M.S., National Center for Health Statistics; Michele 
Chiappa, B.A., Harris Corporation; and Kathryn S. Porter, M.D., 
Yechiam Ostchega, Ph.D., R.N., Brenda G. Lewis, M.P.H., and 
Jennifer Dostal, B.S., National Center for Health Statistics Introduction
 
This National Health and Nutrition 
Examination Survey (NHANES) 
1999–2010 plan and operations report 
provides detailed information on how 
the Division of Health and Nutrition 
Examination Surveys (DHANES), 
within the Centers for Disease Control 
and Prevention’s (CDC) National Center 
for Health Statistics (NCHS), planned, 
implemented, and conducted the 
1999–2010 NHANES. Those who use 
the NHANES public-release data sets 
should find this report helpful in using 
the data sets properly. This report is 
structured by the order in which 
NHANES is planned and implemented. 
The first four sections describe the 
survey history and planning. The 
remaining sections describe the survey 
operations, data collection, and 
information technology. Additional 
information is found in the Appendix, 
which presents a glossary of terms used 
in this report. 
History of NHANES 
The National Health Survey Act of 
1956 provided for a continuing survey 
and special studies ‘‘ . . . to secure 
accurate and current statistical 
information on the amount, distribution, 
and effects of illness and disability in 
the United States . . . ’’ and to provide 
methods and processes to secure this 
statistical information (1). In 1960, the 
U.S. Department of Health and Human 
Services (HHS) merged the National Office of Vital Statistics and the 
National Health Survey program to form 
NCHS (Appendix). NCHS has been 
located in a number of organizations 
within HHS. Since 1987, NCHS has 
been part of CDC (2). To achieve its 
mission of providing information to 
guide actions and policies that improve 
health, NCHS conducts a number of 
major data collection programs, 
including NHANES. 
NHANES is unique in that it 
combines personal interviews with 
standardized physical examinations and 
laboratory tests. The interviews are 
conducted in the home and at a mobile 
examination center (MEC). The physical 
examinations and laboratory tests are 
conducted in the MEC. The purpose of 
NHANES is to collect data about the 
health, nutritional status, and health 
behaviors of the noninstitutionalized 
civilian resident population of the 
United States. From its establishment in 
1959, the survey has been conducted in 
three separate eras: the National Health 
Examination Survey (NHES) era 
(1959–1970), the periodic and 
population-specific NHANES era 
(1971–1994), and the continuous 
NHANES era from 1999 forward (1). 
In 1959, the first National Health 
Examination Survey (NHES I) was 
conducted and focused on selected 
chronic diseases, such as cardiovascular 
disease and diabetes (3). NHES I 
concluded in 1962. The second NHES 
(NHES II) was conducted during 
1963–1965 and focused on the growth 
and development of children aged 6–11 
years (4). The third NHES (NHES III) Page 1 
Page 2 [ Series 1, No. 56 
Table A. National Health Examination Surveys, 1959–1970 
Years Participant 
Survey conducted Number of participants age (years) Focus 
NHES I . . . . . . . . . . . . . . . . . . .  1959–1962	 7,710 interviewed 18–79 Chronic disease 
6,672 examined 
NHES II . . . . . . . . . . . . . . . . . . .  1963–1965	 7,417 interviewed1 6–11 Growth and development – children 
7,119 examined 
NHES III. . . . . . . . . . . . . . . . . . .  1966–1970	 7,514 interviewed 12–17 Growth and development – adolescents 
6,768 examined 
1Represents those children whose parents or guardians responded to a telephone call from an interviewer who collected information on the ages of all children within that household. 
NOTE: NHES is National Health Examination Survey. 
Table B. Periodic and population-specific National Health and Nutrition Examination Surveys, 1971–1994 
Years Participant
 
Survey conducted Number of participants age Focus
 
NHANES I . . . . . . . . . . . . . . .  1971–1974	 28,043 interviewed 1–74 years Nutrition and health 
20,749 examined 
NHANES II . . . . . . . . . . . . . . .  1976–1980	 25,286 interviewed 6 months–74 years Nutrition and health 
20,322 examined 
HHANES . . . . . . . . . . . . . . . .  1982–1984	 13,689 interviewed 6 months–74 years Hispanic nutrition and health 
11,653 examined1 
NHANES III . . . . . . . . . . . . . .  1988–1994	 33,994 interviewed 2 months and over Subpopulation nutrition and health 
30,818 examined 
1Of those examined, participants’ ethnicities were 7,462 Mexican-American, 1,357 Cuban-American, and 2,834 Puerto Rican persons. 
NOTES: NHANES is National Health and Nutrition Examination Survey. HHANES is Hispanic Health and Nutrition Examination Survey. was conducted during 1966–1970 and 
focused on the growth and development 
of adolescents aged 12–17 (5). Because 
the same basic survey design was used, 
nearly one-third of the children 
examined in NHES II were examined 
again in NHES III as adolescents. 
Table A provides further information on 
NHES I, II, and III. 
In 1971, a nutrition component was 
added to the survey, and the survey 
name changed to the National Health 
and Nutrition Examination Survey. This 
began the periodic and population-
specific era (1971–1994), during which 
four surveys were conducted. The first 
NHANES (NHANES I) was conducted 
for 1971–1974 (augmented for 
1974–1975 by an additional national 
sample) and focused on the nutrition 
and health of participants aged 1–74. 
The Augmentation Survey included 
adults aged 25–74 and did not 
oversample any populations. For more 
information on the augmentation, see 
‘‘Plan and Operation of the HANES I 
Augmentation Survey of Adults 25–74 
Years: United States, 1974–1975’’ (6) at 
http://www.cdc.gov/nchs/data/series/ 
sr_01/sr01_014.pdf. The second NHANES (NHANES 
II) was conducted during 1976–1980 
and focused on nutrition and health, but 
the age of eligible participants started at 
6 months. The maximum age of 
sampled participants remained 74 years. 
For 1982–1984, NHANES shifted 
to a population-specific survey. The 
Hispanic Health and Nutrition 
Examination Survey (HHANES) was 
conducted on the three largest Hispanic 
subgroups in the United States at the 
time: Mexican-American, Cuban-
American, and Puerto Rican persons. 
HHANES aimed to produce estimates of 
nutrition and health status for these 
subgroups. HHANES was similar in 
design to NHANES II in that the ages 
of sampled participants were 6 months 
through 74 years. 
In 1988–1994, a third NHANES 
(NHANES III) was conducted in which 
several population groups were 
oversampled, including children aged 2 
months to 5 years, persons over age 60, 
Mexican-American persons, and 
non-Mexican-American black persons. 
Additionally, emphasis was placed on 
the effect of the environment on overall 
health, and, therefore, data were 
collected on environmental exposures (e.g., carbon monoxide, pesticides, and 
others). Table B provides further 
information on NHANES I, II, III, and 
HHANES. 
Starting in 1999, NHANES became 
a continuous, ongoing annual survey of 
the noninstitutionalized civilian resident 
population of the United States. 
NHANES excluded all persons in 
supervised care or custody in 
institutional settings, all active-duty 
military personnel and active-duty 
family members living overseas, and 
any other U.S. citizens residing outside 
of the 50 states and the District of 
Columbia. Noninstitutional group 
quarters were included; for more 
information on group quarters, see 
Appendix. A continuous survey allowed 
content to change to meet emerging 
needs. The goals of the continuous 
NHANES were: 
+	 To provide prevalence data on 
selected diseases and risk factors for 
the U.S. population. 
+	 To monitor trends in selected 
diseases, behaviors, and 
environmental exposures. 
+	 To explore emerging public health 
needs. 
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s+	 To maintain a national probability 
sample of baseline information on 
health and nutritional status. 
The design of the sample changed 
periodically as well. In the continuous 
NHANES, the participant age range was 
expanded to all ages. Data were released 
to the public in 2-year cycles. The 
sample size in a 12-month period was 
approximately 5,000 individuals from 15 
different county locations selected from 
a sampling frame that included all 50 
states and the District of Columbia. 
Oversampled subgroups for 1999–2006 
included non-Hispanic black persons, 
Mexican-American persons, low-income 
white persons (beginning in 2000), 
adolescents aged 12–19, and persons 
aged 70 and over. During 1999–2006, a 
supplemental sample of pregnant women 
was included. Oversampled subgroups 
for 2007–2010 included all Hispanic 
persons, non-Hispanic black persons, 
low-income white persons, and persons 
aged 80 and over. Table C provides 
information on the number of 
participants interviewed and examined 
during the continuous NHANES. This 
report hereafter addresses only the 
continuous NHANES era for 
1999–2010. For more information on 
the history of NHANES, see ‘‘The 
NHANES Story’’ at http://www.cdc.gov/ 
nchs/video/nhanes50th_ppf/intro/ 
ppf_intro.htm. Table C. National Health and Nutrition 
Examination Survey, 1999–2010 
NHANES 
2-year cycle Number of participants 
1999–2000 . . . . .  9,965  interviewed  
9,282 examined 
2001–2002 . . . . .  11,039  interviewed  
10,477 examined 
2003–2004 . . . . .  10,122  interviewed  
9,643 examined 
2005–2006 . . . . .  10,348  interviewed  
9,950 examined 
2007–2008 . . . . .  10,149  interviewed  
9,762 examined 
2009–2010 . . . . .  10,537  interviewed  
10,253 examined 
NOTE: NHANES is National Health and Nutrition Examination 
Survey. 
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cSurvey Planning and 
Sample Design 
A major advantage of continuous 
NHANES data collection is the ability 
to address emerging public health issues 
and provide objective data on health 
conditions for the U.S. population in a 
timely manner. For 1999–2010, 
NHANES content was modified 
biannually as components were added, 
changed, or removed. Changes were 
also made to target new age groups, 
modify data collection methods, and 
update technologies. Prior to biannual 
changes, NHANES conducted pilot tests 
of new or revised survey material as 
part of the ongoing data collection. 
Planning Process 
The NHANES program solicited 
new content proposals in the mid-1990s 
for the launch of the continuous survey, 
and biannually after the survey began. 
Broad oversight for planning and 
content was provided through 
consultation with stakeholders, 
collaborating agencies, and other 
research partners. These parties, as well 
as those on an NHANES mailing list, 
were informed every 2 years of 
deadlines and guidelines for proposals 
for the upcoming 2-year survey cycle. 
This information was also posted on the 
NHANES website. The research 
proposal solicitation process required 
that all persons interested in adding 
content to NHANES submit a letter of 
intent and a full proposal. 
Letters of intent were reviewed by 
the DHANES Planning Branch to 
determine if the proposed content was 
safe, feasible, and of sufficient public 
health significance to include in 
NHANES. If the letter of intent was 
acceptable, the proposer was asked to 
submit a full research proposal. A full 
proposal included details about the 
public health significance and data 
collection methodology. Proposals were 
evaluated based on public health 
significance; appropriateness and 
feasibility given the NHANES design 
and sample; ethical issues; participant urden; and financial considerations. If 
ccepted, the protocol was fully 
eveloped and prepared for field-testing 
rior to use in NHANES. If required, 
ognitive testing and translation 
ctivities were completed prior to field 
mplementation. Similarly, laboratory 
ethods were tested and deemed 
eliable and valid prior to their inclusion 
n NHANES. Accepted proposals for 
ew content and content modifications 
ere summarized in an information 
learance request (ICR) submitted to the 
ffice of Management and Budget 
OMB). An ICR was submitted to OMB 
very 2 years or when amendments 
ere necessary. OMB approved and 
rovided clearance for NHANES to 
egin data collection. All protocols were 
lso reviewed and approved by the 
CHS Research Ethics Review Board 
ERB) prior to implementation in 
HANES; for more information on 
RB, see the ‘‘Ethical, Privacy, and 
onfidentiality Considerations’’ section. 
ample Design 
NHANES was designed to assess 
he health and nutritional status of the 
ivilian noninstitutionalized U.S. 
opulation. NHANES data were not 
btained using a simple random sample. 
ather, a complex, multistage 
robability sampling design was used to 
elect a sample representative of the 
ivilian noninstitutionalized household 
opulation of the United States. 
Sample selection for NHANES 
ollowed these stages, in order: 
.	 Selection of primary sampling units 
(PSUs), which are counties or small 
groups of contiguous counties. 
.	 Selection of segments within PSUs 
that constitute a block or group of 
blocks containing a cluster of 
households. 
.	 Selection of specific households 
within segments. 
.	 Selection of individuals within a 
household; see the ‘‘Household 
Interview’’ section for more 
information on sample person 
selection. 
About 12,000 persons per 2-year 
ycle were asked to participate in 
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year, but an average of 10,500 persons 
out of the initial 12,000 agreed to 
complete a household interview. Of 
these, about 10,000 then participated in 
data collection at the MEC. These 
persons are located in counties across 
the country. About 30 selected counties 
were visited during a 2-year survey 
cycle out of approximately 3,000 
counties in the United States. Each of 
the four regions of the United States and 
metropolitan and nonmetropolitan areas 
are represented each year. 
Demographic Domains and 
Oversampling 
For certain subgroups of particular 
public health interest, the proportion of 
individuals in the NHANES sample was 
larger than the corresponding proportion 
in the U.S. population. This 
oversampling increased the reliability 
and precision of estimates of health 
status indicators for these population 
subgroups. Weighting schemes allowed 
estimates from these subgroups to be 
combined to obtain a national estimate 
that reflected the relative proportions of 
these groups in the population as a 
whole. Oversampled subgroups in the 
survey were: 
For 1999–2006: 
+	 Non-Hispanic black persons 
+	 Mexican-American persons 
+	 Low-income white persons 
(beginning in 2000) 
+	 Persons aged 70 and over 
+	 Adolescents aged 12–19 
For 2007–2010: 
+	 Non-Hispanic black persons 
+	 Hispanic persons 
+	 Low-income white persons 
+	 Persons aged 80 and over 
During 1999–2006, a supplemental 
sample of pregnant women was also 
included. 
Sample Weights 
The weighting of sample data 
permitted analysts to produce estimates 
of statistics they would have obtained if 
the entire sampling frame had been surveyed. A sample weight was assigned 
to each sample person. Sample weights 
were considered measures of the number 
of people represented by the particular 
sample person. When a sample was 
weighted in NHANES, it was 
representative of the U.S. civilian 
noninstitutionalized population. 
Weighting took into account several 
features of the survey: the differential 
probabilities of selection for the 
individual domains; nonresponse to 
survey instruments; and differences 
between the final sample and the total 
population. Weights were adjusted for 
nonresponse to the in-home interview 
when creating the interview weights, 
and further adjusted for nonresponse to 
the MEC examination when creating the 
examination weights. 
Each single year and any 
combination of consecutive years 
comprised a nationally representative 
sample of the population. However, 
because NHANES went to only a small 
number of PSUs each year, estimates for 
single-year data were relatively unstable 
(large variance estimates). In addition, 
releasing only 1 year of data increased 
the possibility of disclosure of a sample 
person’s identity. As a result, data were 
publicly released in 2-year cycles. In 
general, any 2-year data cycle in 
NHANES can be combined with 
adjacent 2-year data cycles to create 
analytic data files based on 4 or more 
years of data, to produce estimates with 
greater precision and smaller sampling 
error. For further details on the 
NHANES sample design, see the 
National Health and Nutrition 
Examination Survey reports on sample 
design for 1999–2006 (7) and 
2007–2010 (8). 
Ethical, Privacy, and 
Confidentiality 
Considerations 
The NHANES protocol was 
developed and reviewed to be in 
compliance with the HHS Policy for 
Protection of Human Research Subjects 
(45 CFR part 46), available from 
http://www.hhs.gov/ohrp/humansubjects/ guidance/45cfr46.html. It was approved 
by the NCHS Research ERB and 
underwent annual review. Three federal 
laws protected all data: 
+	 Privacy Act of 1974 (5 U.S.C. 552a) 
+	 Section 308(d) of the Public Health 
Service Act (42 U.S.C. 242m) 
+	 Confidential Information Protection 
and Statistical Efficiency Act 
(CIPSEA) (PL107–347) 
The Public Health Service Act stipulates 
that ‘‘ . . . no information may be used 
for any purpose other than the purpose 
for which it was supplied unless . . . [a] 
person consented to its use for such 
other purpose, and further that it cannot 
be released or published in a form that 
the particular . . . person supplying the 
information or described in it is 
identifiable unless such . . . person has 
consented . . . ’’ (9). These strict 
prohibitions, forbidding even 
unintentional unauthorized disclosures, 
guided the behavior of all NCHS staff 
and all contractor staff. 
To prevent disclosing information to 
unauthorized persons, all government and 
contractor staff working on NHANES read 
and signed a nondisclosure affidavit, and 
viewed the ‘‘NCHS Confidentiality 
Practices for Federal Employees and 
Contractors’’ video. Each person working 
on the study was aware of his or her 
responsibility to safeguard the rights of all 
NHANES participants. Employees were 
instructed never to divulge names or any 
other information about sample participants 
(those sample persons who take part in the 
survey). They refrained from any 
discussions about sample participants, 
inside or outside of the MEC, which could 
be overheard by people not on the 
NHANES staff. Information kept on 
interviewer tablets and MEC computers 
was secured through password protection, 
encryption, and other information 
technology (IT) security processes; for 
more information about data protection and 
IT, see the ‘‘Data Processing and 
Information Technology’’ section. 
Ethics Review Board 
The NCHS Research ERB protects 
the rights and welfare of people enrolled 
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regulations (45 CFR 46.111), ERB 
reviewed and approved NHANES 
protocols, including ongoing changes to 
the protocol through the amendment 
process. This process ensured the ethical 
treatment of participants, including 
vulnerable populations (e.g., children, 
pregnant women, and the elderly). For 
survey years 1999–2010, ERB reviewed 
and approved the NHANES protocol 
annually. Table D provides information 
on the protocol numbers. 
Informed Consent 
Sample persons were informed of 
the survey process and their rights as a 
participant by interviewers and by 
written materials, such as brochures and 
flyers. After the sample person 
understood the entire NHANES process, 
he or she had the opportunity to consent 
or assent to participate. Participation 
was voluntary. Documented signed 
consent was obtained from sample 
persons who had reached the age of 
maturity in their state (usually age 18 
and over). A parent or guardian gave 
permission for minors to participate. In 
addition, children aged 7–17 provided 
documented assent prior to participating. 
An emancipated minor did not need 
parental permission. For cognitively 
impaired persons, consent was obtained Table D. Protocols: National Health and Nutritio
Survey and years conducted 
NHANES 2005–2010 . . . . . . . . . . . . . . . . . . . .  
NHANES 1999–2004 . . . . . . . . . . . . . . . . . . . .  
NOTES: NHANES is National Health and Nutrition Examination Sur
Table E. Summary of National Health and Nutrit
Sample participant Home 
ages interview consent 
0–11  months  . . . . .  Signed by parent 
1–6 years . . . . . . .  Signed by parent 
7–11 years . . . . . .  Signed by parent 
12–17 years. . . . . .  Signed by parent and 
participant (ages 16 
and 17 only) 
18 years and over . . Signed by participant 
. . . Category not applicable. from guardians, parents, or 
representatives who had the legal right 
to consent to medical care on behalf of 
the impaired person. 
NHANES participation has two 
phases: the home interview and the 
health examination. Signed informed 
consent was obtained from every sample 
person for both phases during the home 
interview. Interpreters were hired as 
necessary to help sample persons who 
did not speak or read English or 
Spanish. 
The consent forms were presented 
to the sample person in a specific order 
to ensure all necessary signatures were 
captured (Table E). The consents are 
described in detail below; for more 
information on consents, see the 
NHANES website at http://www.cdc. 
gov/nchs/nhanes/nhanes2009-2010/ 
current_nhanes_09_10.htm. 
Home interview consent form 
Sample persons aged 12 and over, 
and parents or guardians of sample 
participants aged 18 and under, read and 
signed the Home Interview Consent 
form. If a sample person was unable to 
read the form, the interviewer read the 
entire document to the sample person in 
front of a witness; then the sample 
person signed the form and completed 
the in-home personal interview. If the n Examination Survey, 1999–2010 
NCHS Ethics Review 
Board protocol number 
#2005–2006
 
#98–12
 
vey. NCHS is National Center for Health Statistics. 
ion Examination Survey forms used to complete
Examination Examination 
consent or assent child assent 
Signed by parent . . . 
Signed by parent . . . 
Signed by parent Signed by participant 
Signed by parent and . . . 
participant 
Signed by participant . . . sample person was unable to sign the 
form, a witness signed the form to 
indicate that the sample person gave 
informed consent. 
Examination consent brochure 
and form 
An examination consent form was 
signed by sample persons aged 18 and 
over. This consent was also signed by 
sample persons aged 12 and over, and 
by parents or guardians of sample 
persons aged 18 and under. Sample 
persons (or guardian) aged 7–11 signed 
separate forms; see the ‘‘Child 
examination assent brochure and form’’ 
section. 
Before scheduling an appointment 
in the MEC, the interviewer provided 
the examination consent brochure and 
form, a health measurements list, and 
the consent form to the sample person. 
The ‘‘Examination Consent Brochure’’ 
addressed the general procedures of the 
examination components and goals of 
the survey, discussed data uses and 
confidentiality, and explained the 
voluntary nature of participation and the 
rights of sample persons. The health 
measurements list showed the 
components of the examination, 
including laboratory assessments. As 
with the Home Interview Consent form, 
this material was introduced and 
provided to the sample person so he or 
she could read the information, ask 
questions, and sign the consent form. 
The sample person was given the 
examination brochure and a copy of the 
signed consent form to keep.  consent process 
Non-DNA specimen DNA specimen 
storage consent storage consent 
or assent or assent 
. . . . . . 
Signed by parent . . . 
Signed by parent . . .  
and participant 
Signed by parent . . .  
and participant 
Signed by participant Signed by participant 
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brochure and form 
In addition to parents’ or guardians’ 
signatures on the examination consent 
form, minors aged 7–11 agreed to 
participate in the examination. An assent 
brochure, which was specifically 
designed to explain participation to the 
child and written at a fourth-grade 
reading level, was presented or read 
aloud. Questions were answered, and 
then the child assented by signing his or 
her own name. The minor was given the 
brochure and a copy of the signature 
form to keep. 
Consents for specimen storage 
NHANES sample persons were 
asked to consent to have their blood, 
urine, and saliva specimens stored for 
future studies. The specimen consent 
form highlighted the need for stored 
specimens to help find new ways to 
prevent, treat, and cure many diseases. 
The form was designed to answer 
commonly asked questions posed by 
sample participants. In 2007, the form 
was split into two separate specimen 
storage consents: one for future genetic 
studies, and one for future nongenetic 
studies. 
The ‘‘Consent/Assent and Parental 
Permission for Specimen Storage and 
Continuing Studies’’ form was used for 
sample persons aged 7 and over. The 
sample person was instructed to read the 
consent, mark a checkbox if he or she 
also consented to having his or her 
blood and urine kept for future health 
studies, and sign the consent. The parent 
or guardian of a child under age 18 also 
signed to provide parental permission 
for specimen storage. The ‘‘Consent and 
Parental Permission for Specimen 
Storage and Continuing Studies Using 
DNA’’ form was used for sample 
persons aged 20 and over. The sample 
person was instructed to read the 
consent, mark a checkbox if he or she 
consented to have his or her blood kept 
for future studies that utilized genes to 
understand genetic links to medical 
conditions, and sign the consent. Field Operations
 
NHANES was operationally 
designed to achieve high response rates 
and high-quality data. Field operations 
activities included creating schedules for 
site locations, making arrangements to 
prepare for the arrival of MECs, staffing 
and training, opening the field office, 
setting up the MEC, creating an 
appointment schedule for the MEC, 
opening the MEC, and closing the 
MEC. This section provides detailed 
information on NHANES field 
operations. 
Schedules 
Scheduling site locations was a 
complex task that included multiple 
considerations. Developing the survey 
operations schedule involved the 
sequencing of the annual PSUs (also 
referred to as site locations) and 
determining the dates during which 
individual PSUs would open and close. 
In any annual NHANES cycle, 15 PSUs 
or site locations were selected prior to 
beginning field operations. The calendar 
dates for work in the PSUs were 
determined by several factors: 
+	 Location of the last site in the 
previous year 
+	 Distance between site locations 
+	 Seasonal weather patterns 
+	 Expected number of sample 
participants in the site location 
+	 Expected number of households to 
be screened (Appendix) in the site 
location 
+	 Other factors specific to sites, such 
as difficulties with MEC transit 
After the PSU order was determined, a 
detailed individualized schedule for each 
site location was developed. This 
schedule included dates for travel, 
opening the field office and MEC, 
conducting interviews and examinations, 
and closing the field office and MEC. 
Each site location was open for 
approximately 9 weeks. 
Advance Arrangements 
Advance arrangements were made 
to prepare for the arrival of the survey. Activities included notifying the 
community, obtaining MEC site 
locations, and performing media 
outreach. 
Community notification 
Based on U.S. Census Bureau data, 
a demographic profile of each site 
location was created. Listing information 
was assessed, and NHANES staff 
identified all county officials at a site 
location who needed to be notified of 
the arrival of NHANES. After an initial 
in-person meeting with the local public 
health director, a notification letter was 
sent to county health officials, the area 
agency on aging, local law enforcement, 
county executives, mayors, fire 
departments, and school superintendents 
to inform them of the arrival of 
NHANES. The letter included the 
expected number of participants to be 
examined and offered contact 
information for any questions. County 
health officials, the area agency on 
aging, mayors, and others were asked to 
provide endorsements of NHANES to 
be used by interviewers, if needed. The 
health department was also asked to 
provide a list of medical and dental 
clinics for possible referrals. 
Location for MEC 
Selecting a location for the MEC 
was a critical part of the survey because 
the location could greatly affect the 
survey response rate. A location that was 
familiar to residents with easy access 
from the sampled segments was ideal. 
Plumbing, electrical, sewer, and 
telecommunications hookup capability 
also were required. 
Media outreach 
Prior to household interviewing at a 
site location, NHANES compiled a list 
of local newspapers and media outlets. 
A press kit, which included the press 
release, the NHANES overview 
brochure, and other NHANES materials, 
was sent to these media outlets and 
newspapers. The goal was for an article 
about NHANES to be published in one 
or more local newspapers before data 
collection began. In addition, an open 
house was held during the morning of 
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run’’ section. All local media were 
invited. 
Staffing and Training 
Staff were selected based on 
previous experience, academic training, 
knowledge, skills, and abilities. Many 
positions required that the staff speak 
both English and Spanish. Bilingual 
staff were hired to address the language 
needs of Spanish-speaking sample 
participants. Verbal scripts in the MEC 
were translated into Spanish to assist 
examiners and interpreters in explaining 
testing procedures and to ensure a 
standardized protocol. Interpreters were 
hired to assist interviewers and 
examiners when necessary for any 
language. Sample participants who did 
not speak Spanish or English were 
excluded from examination components 
that contain sensitive information, such 
as the MEC interview and sexually 
transmitted disease (STD) testing. 
A background check and a security 
clearance were completed upon hiring 
each staff member. Field office staff 
(Appendix), including the interviewers, 
and MEC staff traveled with the survey 
and worked 48 weeks of the year. The 
field office staff consisted of a study 
manager, field manager, office manager, 
and assistant office manager at each 
field office. The MEC staff comprised 
two examination teams. Each team 
included the following staff: 
+	 A MEC manager who supervised the 
examination staff and oversaw 
examination flow. 
+	 A coordinator who directed sample 
participants through the MEC, 
managed appointments, and verified 
completion of MEC examinations. 
+	 A physician who conducted medical 
examinations, evaluated for referrals, 
and served as a safety officer. 
+	 Two health interviewers who 
administered questionnaires for 
physical and mental health. 
+	 Two dietary interviewers who 
administered the 24-hour dietary 
recall. 
+	 Four health technologists who 
collected medical examination data such as body measurements, vision 
tests, respiratory health 
examinations, bone density scans, 
hearing tests, and glucose solution 
for the glucose tolerance test. 
+	 Three medical technologists who 
processed biological specimens, 
conducted the complete blood count 
and pregnancy tests, and prepared 
specimens for shipment to 
laboratories across the United States. 
+	 A phlebotomist, who conducted the 
phlebotomy interview, administered 
the fasting questionnaire, drew blood 
for laboratory tests, administered the 
glucose solution, and served as a 
backup examiner for other 
components. 
In addition to those listed, a dental 
hygienist performed the oral health 
component for 2009–2010. A dentist (or 
dental examination team made up of a 
dentist and an oral health recorder) 
performed the oral health component for 
1999–2004. Health technologists were 
used in the interim. 
Annual retraining was conducted for 
all staff (field office, interviewer, and 
MEC) to make certain that they were 
updated on changes to components and 
protocols and procedures, and that they 
were introduced to new content. 
Information on initial training for the 
MEC staff and field office staff follows. 
Field office staff training 
The field office staff attended a 
10-day interviewer-training course so 
that they were proficient in the 
mechanics of sample participant 
recruitment and household interviewing. 
The field office staff spent 4 to 5 days 
learning general field-office procedures 
and specific details about their roles. 
The training also educated the staff on 
how to perform manual opening and 
closing of site locations, manage case 
workflow using an automated system, 
monitor site production using daily 
reports, and comply with procedures for 
handling sample participant queries, 
documentation, and refusals. 
Interviewer training 
Training was designed to make new 
interviewers proficient at making contact with residents of sampled households, 
using screening techniques properly, and 
obtaining consent to participate from 
selected individuals. The interviewer 
training program consisted of a 10-day 
course and covered: 
+	 The purpose and goals of NHANES 
and how to properly encourage 
participation. 
+	 The adherence to confidentiality and 
high performance standards required 
for data collection. 
+	 The administration and navigation of 
the interview, which includes three 
computerized household 
questionnaires. 
+	 The case workflow and appropriate 
use of survey materials. 
+	 The administrative procedures for 
personnel working in the field 
environment. 
New interviewers shadowed seasoned 
interviewers for a period of time prior to 
interviewing on their own. 
MEC staff training 
The MEC staff was trained 
according to their specific jobs. Each 
examination component in the MEC 
involved multiple roles and 
responsibilities; therefore, each MEC 
staff member was trained by a subject 
matter expert. MEC staff training was 
rigorous and done through procedure 
demonstrations and practice. Training 
included: 
+	 Learning about the objectives and 
goals of the examination component. 
+	 Demonstrations of protocols and 
procedures. 
+	 Practicing the procedures. 
+	 Learning about quality control and 
quality assurance. 
+	 Learning how to maintain and 
perform calibrations on the 
equipment. 
+	 Learning the MEC opening and 
closing protocols. 
+	 Learning to maintain the inventory 
for supplies. 
Site visits by DHANES staff were done 
throughout the year to observe MEC 
staff as part of quality assurance. 
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SOURCE: CDC/NCHS, National Health and Nutrition Examination Survey, MEC 2010. 
Figure. Floor plan of a mobile examination center used in the National Health and Nutrition 
Examination Survey, 2010 Opening the Field Office 
The NHANES field office was 
located in the PSU. The field office 
supported activities regarding household 
interviewing and MEC data collection. 
Activities included coordinating 
procedures (e.g., monitoring site 
production), managing household case 
assignments and refusal conversion 
efforts, scheduling examination 
appointments, and handling staffing 
issues. 
Opening the field office required 
hiring a local receptionist; preparing 
case assignments for field interviews; 
preparing a map and directions to the 
MEC for sample participants; receiving 
survey supplies; setting up computer 
equipment, telephones, and common 
areas; and becoming familiar with the 
sample area (Appendix). The field office 
opened 1 week before interviewing 
began and remained open until the MEC 
examinations ended. 
Mobile Examination 
Center 
Trailer design 
NHANES was designed to collect 
data by direct physical examinations, 
clinical laboratory tests, and related 
measurement procedures. Data were 
collected in a standardized environment 
to minimize site-specific error. Each 
MEC was a group of four trailers set up 
side by side and connected by enclosed 
passageways (Figure). NHANES 
1999–2010 included three MECs, two of 
which were actively used for data 
collection while the third traveled to a 
new location. The layout was identical 
in all three MECs to avoid bias in data 
collection between MECs. A MEC tour 
is available at http://www.cdc.gov/nchs/ 
nhanes/mec_tour/mectour.htm. 
All supplies, tools, and materials 
introduced to the MEC environment 
were evaluated before they were used. 
Each MEC had a reception area, nine 
examination rooms, four interview 
rooms, a laboratory, three restrooms, and 
a staff lounge. Specific customizations (e.g., a soundproof booth for
 
audiometry) were featured in each MEC.
 
Examination rooms 
The nine MEC examination rooms 
varied in size depending on the 
requirements of the component. For 
example, a larger room was designated 
for the dual-energy X-ray 
absorptiometry, or DXA, instrument. 
MEC rooms were modified as necessary 
to accommodate new components. 
Safety and special 
accommodations 
The safety of the MEC staff and 
sample participants was an NHANES 
priority. Special accommodations in the 
MEC included a handicapped restroom 
with handrails, a hydraulic wheelchair 
lift, and a baby changing table. The 
MEC was a nonsmoking facility. Fire 
extinguishers were placed throughout the MEC, and exit doors were 
highlighted in every trailer. The 
following was kept in the physician’s 
examination room for emergency 
response: 
+ Emergency medical kit 
+ Automated external defibrillator 
+ Two portable oxygen tanks 
+ Portable blood pressure equipment 
Pocket masks for cardiopulmonary 
resuscitation, or CPR, were located 
throughout the MEC, and examination 
staff maintained current certification in 
the American Heart Association’s Basic 
Life Support for Healthcare Providers. 
Mock emergency drills were held 
periodically in the MEC to permit 
practice of the emergency procedures. 
Telephone numbers for local fire and 
rescue squads were posted in the MEC, 
and ‘‘911’’ was used to initiate the local 
emergency response system. 
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Table F. Remuneration amount per participant: National Health and Nutrition Examination 
Survey, 1999–2010 
Attending assigned Attending alternative 
Survey years Participant circumstance session session
1999–2000. . . . . . . . 
  
2001–2004. . . . . . . . 
  
2005–2008. . . . . . . . 
  
2009–2010. . . . . . . . 
  
Aged  12  and  over $70 $40
 
Person with diabetes on insulin 40 40
 
Under age 12 30 30
 
Aged  16  and  over 100 70 
Person with diabetes on insulin 70 70 
Aged 12–15 50 30 
Under age 12 30 30 
Aged  16  and  over 100 70 
Aged 12–15 50 30 
Under age 12 30 30 
Aged  16  and  over 125 90 
Aged 12–15 90 40 
Under age 12 40 40 Setup and dry run 
Prior to conducting examinations in 
the MEC, the trailers were set up with 
the proper equipment and supplies 
needed for each component. Once the 
MEC was set up, the equipment was 
calibrated and tested to ensure proper 
functioning. NHANES held a ‘‘dry-run’’ 
day to test the equipment. The dry run 
usually occurred the day before 
examinations began and allowed for 
practice examination sessions to be 
administered for each component using 
volunteer examinees. In addition, blood 
and urine were collected and sent to 
laboratories. Randomly selected dry-run 
specimens were also sent with alternate 
identification numbers for blind 
duplicate quality control. 
Appointment schedule 
An appointment for an examination 
in the MEC was scheduled for each 
sample participant when the interviewer 
was in the participant’s home. That 
interviewer called the field office to set 
up the appointment. Each sample 
participant was randomly assigned a 
morning appointment or an afternoon or 
evening appointment. If a sample 
participant was unable to attend his or 
her assigned session, he or she made an 
alternative appointment. An individual 
examination could last between 40 
minutes and 4 hours, depending on the 
age and gender of the sample 
participant. 
Each examination session was 4 hours 
and could include 10–12 sample 
participants. If a sample participant was 
assigned to a morning appointment, he or 
she was asked to fast prior to the 
appointment. The average time between 
interview and examination was 2 weeks. A 
reminder letter was mailed to the 
participant 1 week before the scheduled 
exam. The reminder letter included the date 
and time of the appointment, transportation 
information, directions to the MEC, 
appropriate fasting instructions, and the 
remuneration (cash payment) amount. 
Forty-eight hours before a MEC 
examination appointment, the field office 
staff called the participant to remind him or 
her of the upcoming appointment. 
Instructions related to the MEC appointment were reviewed. If the 
participant did not have a telephone, the 
interviewer visited the home to provide an 
in-person reminder. 
Opening and closing 
Once examinations began, the MEC 
was open 5 days a week and operated 
on a rotating schedule to allow sample 
participants to choose from a variety of 
appointments. The MEC was closed 2 
days a week, and these days changed 
from week to week. The MEC typically 
remained open for 6 weeks. Once 
examinations were concluded in a 
specific location, the MEC closed and 
went through ‘‘teardown.’’ This involved 
checking the inventory, repacking 
supplies, securing equipment, and 
preparing for travel. The MEC then 
traveled to the next assigned location. 
Remuneration 
NHANES had other approaches for 
gaining participation, which included 
remuneration and a transportation 
allowance. NHANES materials were 
available in both English and Spanish. 
Sample participants were remunerated at 
the conclusion of their examination 
appointment. The amount of the 
remuneration depended on the sample 
participant’s age and the session 
attended. Table F shows the 
remuneration amounts by survey year, 
participant circumstance, and session. 
Each sample participant’s session 
was randomly assigned for morning, afternoon, or evening, as stated above. 
Sample participants were fully 
compensated for coming to their 
assigned session, but were not fully 
compensated if they attended a 
nonassigned session. Remuneration was 
also given to a parent or guardian if his 
or her child was selected to participate 
but he or she was not. 
Sample participants also received a 
transportation allowance for driving to 
the MEC. If a sample participant did not 
drive, a taxi was provided at no cost. 
Table G has information on the 
transportation allowance provided based 
on survey year, mileage to the MEC 
location, and whether the location was 
urban or rural. For information on 
additional remuneration for other 
components, see the ‘‘Post-MEC Data 
Collection’’ section. 
Household Interview 
The NHANES household interview 
consisted of four parts: screener 
questionnaire, relationship questionnaire, 
sample participant questionnaire, and 
family questionnaire. Trained household 
interviewers administered the 
questionnaires in the sample 
participant’s home. In very rare 
instances, the household interview took 
place outside of the home (i.e., in the 
field office or a public location). The 
interview was conducted using a 
computer-assisted personal interview 
system and Blaise software. Interpreters 
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Table G. Transportation allowance: National Health and Nutrition Examination Survey, 
1999–2010 
Survey years	 Mileage to MEC1 location Urban Rural 
1999–2006. . . . . . . . . . . . . . . . . . . .  Less than 16 miles 
16–30 miles 
31–59 miles 
More than 60 miles 
$25 
35 
45 
55 
$20 
30 
40 
50 
2007–2010. . . . . . . . . . . . . . . . . . . .  Less than 16 miles 
16–30 miles 
31–59 miles 
More than 60 miles 
30 
45 
55 
70 
25 
40 
50 
65 
1Mobile examination center. for the household interviews were used 
for non-English/non-Spanish 
participants. Table H provides details on 
each section of the household interview. 
Specific household interview questions 
may have changed during the 2-year 
survey cycles, but the most recent major 
topics are included in Table H; see 
respective data documentation available 
from the NHANES website: http:// 
www.cdc.gov/nchs/nhanes/nhanes_ 
questionnaires.htm. Some household 
interview sections were related to 
examination components, laboratory 
tests, or the MEC interview; see the 
NHANES Survey Content Brochure at 
http://www.cdc.gov/nchs/data/nhanes/ 
survey_content_99_12.pdf for more 
information. 
Screener 
Prior to screening, households were 
sent a letter introducing NHANES and 
providing information that the household 
address had been selected as part of the 
NHANES sample. Each screener case 
assignment consisted of a sampled 
household address and a randomly 
assigned, computer-generated message 
explaining what sex, age, and race or 
ethnicity was necessary for the specific 
address. The field interviewer did not 
know in advance if anyone in the 
household would be selected to be a 
participant. In most cases, the screener 
was conducted on the doorstep. 
The field interviewer arrived at the 
home, showed an official identification 
badge, and briefly explained the 
survey’s purpose. As a reminder, the 
field interviewer showed the notification 
letter stating that the household address 
was part of the NHANES sample. The 
field interviewer conducted the screener questionnaire to enumerate the 
household and to determine eligibility to 
participate further in NHANES. The 
screener gathered information regarding 
each resident’s age, gender, race and 
ethnicity, and income. Based on the 
questionnaire information collected, a 
computer algorithm randomly selected 
one, some, all, or none of the household 
residents to participate. If no one from 
the house was selected, it was because 
no household member met the criteria 
selected by the algorithm. If eligible 
individuals were identified, the 
interviewer proceeded with the 
relationship questionnaire. 
Certain circumstances prevented an 
interviewer from completing a screener 
questionnaire, such as: 
+	 A vacant unit or residence. 
+	 An address not qualifying as a 
dwelling unit. 
+	 A nonexistent sampled dwelling 
unit. 
+	 A household resident refusing 
participation. 
Relationship Questionnaire 
If at least one household member was 
eligible to participate, the relationship 
questionnaire was administered after the 
screener. The intent of the relationship 
questionnaire was to divide all household 
residents into individual family units, to 
determine how many family units were in 
each household. The U.S. Census Bureau’s 
Current Population Survey (CPS) family 
definitions were used, to ensure that the 
appropriate number of family 
questionnaires was created by the software 
administered by the field interviewer. All 
eligible screener and relationship 
questionnaire respondents were adult 
household members at least age 18 or an emancipated minor (criteria determined by 
state law). 
Sample Person 
Questionnaire 
Prior to conducting the sample 
participant or family questionnaires, 
sample participants (aged 18 and over) 
were asked to sign a home interview 
consent form, agreeing to participate in 
the household interview portion of the 
survey; see the ‘‘Ethical, Privacy, and 
Confidentiality Considerations’’ section 
for informed consent procedures. 
Sample participants aged 16 and 17 
were asked to sign a document of 
assent. Parents or guardians of 
participants under age 18 gave parental 
permission. Eligible sample participants 
within a household were asked to 
complete the sample participant 
questionnaire. Field interviewers 
were trained to conduct the sample 
participant questionnaire prior to the 
family questionnaire, because the family 
questionnaire has content that is more 
sensitive. The sample participant 
questionnaire collected information on 
the sample participant’s demographic, 
socioeconomic, dietary, and health-
related history. The sample participant 
questionnaire was administered to all 
eligible participants or their proxies; 
however, each questionnaire section 
administered depended on the sample 
participant’s age (Table H). 
Family Questionnaire 
The family questionnaire was 
completed for every family unit (e.g., a 
married couple, a couple living as 
married, and others) sampled within the 
household. CPS family definitions were 
used. More than one ‘‘family’’ applied 
to households where unrelated persons 
were residing (e.g., roommates, lodgers, 
guests without permanent housing, and 
others). The family questionnaire asked 
questions about each sample participant 
as well as the nonsampled head of the 
family. The questionnaire included 
sections related to education level, 
ethnicity, occupation, health insurance 
coverage, and family income. 
Information on general household 
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more information on the screener, 
relationship questionnaire, sample 
participant questionnaire, and family 
questionnaire, see the NHANES website 
at http://www.cdc.gov/nchs/nhanes/ 
nhanes2009-2010/questexam09_10.htm. 
Household Water 
Collection Component 
At the conclusion of the household 
interview, the field interviewer collected 
a water sample in households with a 
sample participant aged 12 or over. The 
water collection component consisted of 
the field interviewer collecting a single 
tap water sample from the bathtub the 
sample participant used, or from any 
nonaerated spigot. The water sample 
was tested for volatile organic 
compounds (VOCs) and perchlorates 
only in a subsample of households. The 
household water sample test results were 
then linked to the appropriate sample 
participants who were part of the 
VOC/perchlorate water subsample; see 
the ‘‘MEC Biospecimen Collection’’ 
section for more information on 
laboratory tests on water. 
MEC Examinations 
and Interviews 
NHANES examinations took place 
in the MEC. The controlled environment 
of the MEC allowed physical 
measurements to be done under identical 
conditions at each survey location. This 
section addresses examination 
components and interviews conducted in 
the MEC for 1999–2010. Eligibility for 
examination components was 
determined by the participant’s age and 
gender. Some MEC examinations are 
related to a household interview section 
or laboratory test. Procedures and 
protocols for each component can be 
found in each component’s procedures 
manual on the NHANES website at 
http://www.cdc.gov/nchs/nhanes/ 
nhanes_questionnaires.htm. MEC Examination 
Components 
Table J summarizes NHANES MEC 
examination components for 1999–2010. 
Audiometry 
The audiometry component obtained 
data on hearing impairment, identified 
risk factors for hearing loss, and 
monitored early hearing losses 
consistent with overexposure to noise. 
The audiometry component consisted of 
four parts: (a) a pre-examination 
audiometric questionnaire, (b) a brief 
otoscopic screening (physical) 
examination of the ear canals and 
eardrums, (c) tympanometry, and (d) 
pure tone air conduction audiometry. 
This component was conducted on 
sample participants aged 20–69 for 
1999–2004, and participants aged 12–19 
and 70 and over for 2005–2010. 
Anthropometry 
The anthropometry component 
obtained data on selected body measures 
to be able to: (a) provide estimates on 
the prevalence of obesity and related 
measures; (b) study the association 
between body measures and such health 
conditions and risk factors as 
cardiovascular disease, diabetes, 
hypertension, and activity and dietary 
patterns; and (c) monitor growth and 
development in children. Thirteen body 
measurements were collected on sample 
participants. Age ranges varied for each 
body measurement. This component was 
conducted during 1999–2010. 
Balance 
The balance component examined 
normal and abnormal balance in adults, 
and the relationship between balance 
disorders and other factors. The protocol 
consisted of two parts: (a) a short 
pre-examination screening questionnaire, 
and (b) a modified Romberg Test of 
Standing Balance on Firm and 
Compliant Support Surfaces. The 
balance component was conducted on 
sample participants aged 40–69 for 
1999–2000, and sample participants aged 40 and over for 2001–2004. 
Bioelectrical impedance analysis 
The bioelectrical impedance 
analysis, or BIA, component measured 
the electrical impedance of body tissues 
and assessed fluid volumes, total body 
water, body cell mass, and fat-free body 
mass. This component was conducted on 
sample participants aged 8–49 for 
1999–2004. 
Blood pressure 
See ‘‘Physician examination’’ in this 
section. 
Cardiovascular fitness 
The cardiovascular (CV) fitness 
component obtained data on CV fitness 
to (a) provide prevalence estimates of 
persons at risk due to poor physical 
fitness, and (b) study the association 
between CV fitness and other health 
conditions and risk factors, such as 
obesity, CV disease, diabetes, 
hypertension, activity, and dietary 
patterns. CV fitness was assessed with a 
submaximal treadmill test (not a 
maximal test to exhaustion) on sample 
participants aged 12–49. This 
component was conducted for 
1999–2006. 
Dermatology 
The dermatology component 
obtained data to assess the prevalence of 
psoriasis and hand dermatitis in the 
adult population. Four digital images 
were taken by a health technician using 
a Kodak DCS760 digital camera with a 
50mm lens. The poses were: ‘‘BACK 
with ELBOWS,’’ ‘‘INNER ARM,’’ 
‘‘FRONT OF LEGS with HANDS,’’ and 
‘‘BACK OF LEGS with PALMS.’’ The 
dermatology component was conducted 
on sample participants aged 20–59 
during 2003–2004. 
Dual-energy X-ray 
absorptiometry 
The dual-energy X-ray 
absorptiometry, or DXA, component 
obtained data to assess overall skeletal 
Table H. Household interview: National Health and Nutrition Examination Survey, 1999–2010 
Questionnaire and section name Description Survey years Age (years)1 
Screener 
Screener module #1 . . . . . . . . . . .  Enumeration  of  the  household to determine eligible participants; administered at doorstep 1999–2010 18 and over 
Relationship 
Screener module #2 . . . . . . . . . . .  Determined  relationships of household members to others in household 1999–2010 18 and over 
Sample participant 
Acculturation . . . . . . . . . . . . . . . .  Participant asked what language is spoken in the home 1999–2010 12 and over 
Air  quality  control  . . . . . . . . . . . . .  Questions regarding if the air quality was bad, whether the participant did anything differently and, if so, what they did 2007–2010 16 and over 
Allergy  .  . . . . . . . . . . . . . . . . . . .  Questions regarding if diagnosed with allergies, whether had allergy attack in past year, avoided or removed pets from 2005–2006 1 and over 
home because of allergies, type of allergies, age at diagnosis, and allergy symptoms (e.g., rash or sinus infection) 
Arthritis  . . . . . . . . . . . . . . . . . . .  Questions regarding pain in the back, neck, or hip area 2009–2010 20–69 
Audiometry  . . . . . . . . . . . . . . . . .  Questions regarding quality of hearing, whether participant ever had tubes in ears, more than three ear infections, a 1999–2010 1 and over 
hearing aid or other devices, how often hearing aid was worn, whether ringing or buzzing was ever present, if bothered by 
those symptoms, whether participant’s job or personal life required being around loud noises or firearms, and whether 
hearing protection was used in those instances 
Balance . . . . . . . . . . . . . . . . . . .  Questions regarding dizziness, falling, treatment if any, result of treatment, and blood relatives with same condition 1999–2004 40 and over 
Blood pressure. . . . . . . . . . . . . . .  Questions related to high blood pressure diagnosis and treatment 1999–2010 16 and over 
Cardiovascular disease . . . . . . . . .  Questions regarding chest pain, when the pain occurs, how often, whether it stops when physical activity stops, length of 1999–2010 40 and over 
time it usually occurs, and whether participant also has shortness of breath or pain in arms, legs, or neck 
Cardiovascular fitness . . . . . . . . . .  Questions regarding any restrictions on playing sports, recommended physical activity from physician, pain during 2003–2004 12–49 
physical activity, balance and dizziness problems, and problems walking 
Cognitive functioning . . . . . . . . . . .  Participants were asked if they wore reading glasses, then they were asked to manually copy symbols shown on a 1999–2002 60 and over 
computer screen; no additional questions followed the exercise 
Demographic information . . . . . . . .  Questions regarding education, marital status, military service, and other demographic 1999–2010 All ages from birth 
information 
Dermatology  . . . . . . . . . . . . . . . .  Questions regarding skin and skin diseases, sun exposure, and sun protective behavior 1999–2010 20–59 
Diabetes. . . . . . . . . . . . . . . . . . .  Questions regarding diagnosis of diabetes, age at diagnosis, history of prediabetes, taking insulin, how much insulin, how 1999–2010 1 and over 
often taken, blood tests done in the past year, how often and how much glucose is checked, and how often a doctor or 
diabetes specialist is seen 
Dietary screener . . . . . . . . . . . . . .  Questions regarding food or drink consumed in the past month 2009–2010 2–11 
Dietary supplements and prescription 
medications  . . . . . . . . . . . . . . . .  Questions regarding dietary supplements, nonprescription antacids, prescription medications, and asthma medications 1999–2010 All ages from birth 
Dietary behavior and nutrition. . . . . .  Questions regarding breastfeeding and length of time; milk consumption, type, and amounts; whether participant ate 
school lunches or breakfasts, was part of a government-sponsored meal program, and how often already-prepared meals 
were eaten compared with homemade meals; and whether the participant had food allergies or was a vegetarian 1999–2010 All ages from birth 
Dust  collection  . . . . . . . . . . . . . . .  Questions related to location of dust collection 2001–2004 1 and over 
Early childhood . . . . . . . . . . . . . .  Questions regarding birth, birthweight, and current weight 1999–2010 Birth–15 
Health insurance. . . . . . . . . . . . . .  Questions regarding type of insurance coverage, coverage of prescription drugs, and uninsured status during the past 12 
months 2005–2010 All ages from birth 
Hospital utilization and access to 
care. . . . . . . . . . . . . . . . . . . . .  Questions regarding overall health and access to medical care 1999–2010 All ages from birth 
Immunization  . . . . . . . . . . . . . . . .  Questions regarding history of hepatitis A, hepatitis B, and human papillomavirus vaccines and the doses received for 
each 1999–2010 All ages from birth 
Introduction and verification . . . . . . .  Verification  of  gender, date of birth, age, and full name 1999–2006 All ages from birth 
Kidney conditions . . . . . . . . . . . . .  Questions regarding kidney conditions, such as kidney stones and dialysis 1999–2010 20 and over 
Medical conditions. . . . . . . . . . . . .  Questions regarding the presence of different medical conditions, such as asthma and celiac disease 1999–2010 1 and over 
Miscellaneous pain . . . . . . . . . . . .  Questions regarding pain in areas of body and length of time pain was present 1999–2004 20 and over 
Occupation . . . . . . . . . . . . . . . . .  Questions regarding hours worked in previous week, type of work done, how long employed, and whether exposed to 
fumes of any kind 1999–2010 16 and over 
See footnote at end of table. 
P
a
g
e
 
1
2
 
[
 
S
e
r
i
e
s
 
1
,
 
N
o
.
 
5
6
 
Table H. Household interview: National Health and Nutrition Examination Survey, 1999–2010—Con. 
Questionnaire and section name Description Survey years Age (years)1 
Sample participant—Con. 
Oral health . . . . . . . . . . . . . . . . .  Questions regarding the health of teeth and gums 1999–2010 30 and over 
Osteoporosis . . . . . . . . . . . . . . . .  Questions regarding fractured bones, how fractures occurred and how many times, whether diagnosed with osteoporosis, 1999–2010 20 and over 
treatments if any, and family history of fractures or osteoporosis 
Physical activity and physical fitness . . . Questions regarding how many days a week more than 1 hour of physical activity is done, hours on the computer in the past 30 
days, hours watching TV in the past 30 days, and types and frequency of physical activities 1999–2010 2 and over 
Physical functioning . . . . . . . . . . . .  Questions  regarding long-term impairments, health problems, special education and assistance, work limitations, and physical and 
emotional limitations 1999–2010 5 and over 
Respiratory health and disease . . . . . .  Questions  regarding trouble breathing, persistent cough, duration of cough, phlegm, and restlessness due to cough or breathing 
problems 1999–2010 1 and over 
Sleep  disorders  . . . . . . . . . . . . . . .  Questions  regarding trouble sleeping and diagnosis of sleep disorder 2005–2010 16 and over 
Smoking and tobacco use . . . . . . . . .  Questions  regarding smoking in the past 5 days, type of tobacco used (e.g., cigar, cigarette, pipe, chewing, and others), how 
many of those tobacco products were smoked per day, and whether participant is trying to quit 1999–2010 20 and over 
Social support . . . . . . . . . . . . . . . .  Questions  regarding whether participant has emotional support, who from, in need of more support, attends church, needs finan­
cial help, and has close friends available to help 1999–2008 60 and over 
Tuberculosis  . . . . . . . . . . . . . . . . .  Questions  regarding previous tuberculosis (TB) skin tests, TB symptoms, and active TB symptoms 1999–2000 1 and over 
Vision. . . . . . . . . . . . . . . . . . . . .  Questions  regarding blindness; eyesight quality with glasses or contacts; difficulty performing regular daily activities; 
history of cataracts, glaucoma, or macular degeneration; and treatments, if any 1999–2008 20 and over 
Weight  history  . . . . . . . . . . . . . . . .  Questions  regarding self-perception of weight, self-reported weight over the participant’s lifetime, attempted weight loss during the 
past year, and methods used to try to lose weight and to keep from gaining weight 1999–2010 16 and over 
Family 
Demographic background and 
occupation  .  . . . . . . . . . . . . . . . .  Questions  regarding demographics, such as place of birth and education, and occupation 1999–2010 18 and over 
Consumer behavior. . . . . . . . . . . . .  Questions  regarding eating habits of family and how much money is spent on food 2007–2010 18 and over 
Food security . . . . . . . . . . . . . . . .  Questions  regarding food eaten in the last 12 months and the reasons why certain foods were not eaten 1999–2010 18 and over 
Health  insurance  . . . . . . . . . . . . . .  Questions  regarding family and participant health coverage; kind of coverage; whether plan included dental, limited to specific 
doctors or could choose, and HMO or PPO; lack of health insurance in the last year; and discontinued health 
insurance and why 1999–2004 18 and over 
Housing  characteristics. . . . . . . . . . .  Questions  regarding how many rooms in dwelling unit, how long family has lived there, and year it was built 1999–2010 18 and over 
Income . . . . . . . . . . . . . . . . . . . .  Questions  regarding family income; whether income was from a job, Social Security, retirement benefits, disability 
pension, or state assistance programs; and how much income 1999–2010 18 and over 
Pesticide  use  . . . . . . . . . . . . . . . .  Questions  regarding products used in or outside of the home 1999–2004 18 and over 
Smoking  . . . . . . . . . . . . . . . . . . .  Questions  regarding smoking in the household, who smokes, and how often 1999–2010 18 and over 
Tracking and tracing . . . . . . . . . . . .  Questions  regarding the spelling of names and street addresses of two persons not related to the family 1999–2010 18 and over 
1As of 2010. Ages may have been changed from 2-year cycle to 2-year cycle within the continuous National Health and Nutrition Examination Survey (NHANES). However, those changes are not listed here; for more information, see the NHANES website 
at http://www.cdc.gov/nchs/nhanes.htm. 
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Table J. Physical examination components at mobile examination center: National Health and Nutrition Examination Survey, 1999–2010 
Component Description Survey years 
Audiometry  . . . . . . . . . . . . . . . . .  Hearing  test  1999–2010 
Anthropometry . . . . . . . . . . . . . . .  Body  measurements such as height, weight, and waist circumference 1999–2010 
Balance . . . . . . . . . . . . . . . . . . .  Modified  Romberg  test  of  balance 1999–2004 
Bioelectrical impedance analysis . . . .  Estimation  of  fluid  volumes,  total  body water, and fat-free body mass 1999–2004 
Blood pressure. . . . . . . . . . . . . . .  Measurement of systolic and diastolic brachial artery pressure 1999–2010 
Cardiovascular fitness . . . . . . . . . .  Determination  of  heart rate during a submaximal treadmill test 1999–2006 
Dermatology  . . . . . . . . . . . . . . . .  Assessment for selected skin conditions from digital images of skin 2003–2004 
Dual-energy X-ray absorptiometry . . . Measurement of body composition and bone density 1999–2010 
Lower extremity disease . . . . . . . . .  Determination  of  ankle brachial pressure index; assessment for peripheral neuropathy 1999–2004 
Muscle strength . . . . . . . . . . . . . .  Strength test of knee flexion and extension; timed walk 1999–2002 
Ophthalmology  . . . . . . . . . . . . . . .  Visual field testing; grading of digital retinal images for retinal conditions (see ‘‘Vision’’) 2005–2008 
Oral health . . . . . . . . . . . . . . . . .  Assessments of oral diseases and conditions including dental caries, periodontal 1999–2010 
disease, and other conditions 
Respiratory health . . . . . . . . . . . . .  Lung function testing and measurement of exhaled nitric oxide 2007–2010 
Tuberculin skin test . . . . . . . . . . . .  Tuberculin skin test 1999–2000 
Vision  . . . . . . . . . . . . . . . . . . . .  Assessments of near and distance visual acuity (see ‘‘Ophthalmology’’) 1999–2008 changes that often occur with age. This 
component measured bone mineral 
content and bone mineral density. A 
body composition (whole-body) scan 
was conducted to determine fat mass, 
lean tissue mass, bone mineral content, 
and total body fat percentage. This 
component was conducted on sample 
participants aged 18 and over in 1999, 
aged 8 and over for 2000–2004, and 
aged 8–69 for 2005–2006. Scans of the 
femur and anterior-posterior spine were 
conducted on sample participants aged 8 
and over for 2005–2010. Femur scans 
provided bone measurements for the 
total femur, femoral neck, trochanter, 
intertrochanter, and Ward’s triangle. 
Spine scans provided bone 
measurements for the total spine and 
vertebrae L1–L4. 
Lower extremity disease 
The lower extremity disease (LED) 
component collected data to provide 
prevalence of diagnosed and undiagnosed 
LED, including those at high risk for late 
complications of the disease (i.e., ulceration 
and amputation). The two major 
manifestations of LED are peripheral 
vascular disease and peripheral neuropathy. 
Peripheral vascular disease was evaluated 
using the ankle brachial pressure index. 
Peripheral neuropathy was assessed by a 
sensory examination of the feet using a 
monofilament. Both tests were conducted 
on sample participants aged 40 and over. 
This component was conducted for 
1999–2004. Muscle strength 
The muscle strength component 
(also called physical functioning) 
assessed lower body strength. Isokinetic 
strength of the knee extensors and 
flexors was measured. The muscle 
strength component was conducted on 
sample participants aged 50 and over 
who were also asked to do a measured 
walk in addition to the isokinetic 
testing. The 20-foot measured walk and 
isokinetic testing were conducted during 
1999–2002. The 8-foot measured walk 
was conducted during 2000–2002. 
Ophthalmology 
The ophthalmology component 
obtained data to assess the prevalence of 
vision loss and retinal diseases, such as 
macular degeneration. Two eye 
examinations were completed for this 
component: (a) a visual field test using 
frequency-doubling technology, or FDT, 
perimetry and (b) digital fundus 
photography using an ophthalmic digital 
imaging system to assess the presence 
of diabetic retinopathy, age-related 
macular degeneration, and other retinal 
diseases (see also the following 
‘‘Vision’’ section). The ophthalmology 
component was conducted on sample 
participants aged 40 and over for 
2005–2008. 
Oral health 
The oral health component obtained 
data to monitor oral health status, including 
risk factors for disease and access to preventive and treatment services. Many 
assessments have cycled in and out since 
1999. Table K shows the oral health 
assessments for 1999–2010. 
Peripheral neuropathy 
See ‘‘Lower extremity disease’’ in 
this section. 
Physician examination 
The physician examination consisted 
of a blood pressure assessment on 
participants aged 8 and over, radial pulse 
rate determination on participants aged 5 
and over, and apical heart rate auscultation 
on infants from birth to age 4 years. The 
blood pressure assessment obtained data to 
assess the prevalence and trends in 
hypertension, and monitored risk factors for 
major cardiovascular conditions. This 
component was conducted during 
1999–2010. 
The physician examination also 
consisted of: 
+	 Pretest counseling for STD testing. 
+	 Providing instructions to females on 
using a swab for self-collecting a 
vaginal fluid specimen for selected 
STD tests. 
+	 Counseling participants who have 
abnormal findings. 
+	 Managing medical emergencies in 
the MEC. 
Respiratory health 
The exhaled nitric oxide (ENO) 
component collected data to provide a 
noninvasive marker of airway 
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Table K. Oral health: National Health and Nutrition Examination Survey, 1999–2010 
Assessment Participants’ age (years) Survey years 
Basic screening exam . . . . . . . . . . . . . . . . .  5  and  over 2005–2008 
3–19 2009–2010 
Coronal caries . . . . . . . . . . . . . . . . . . . . . .  2  and  over 1999–2004 
Dental sealants. . . . . . . . . . . . . . . . . . . . . .  2–34 1999–2004 
Fluorosis. . . . . . . . . . . . . . . . . . . . . . . . . .  6–49 1999–2004 
6–19 2009–2010 
Functional occlusal . . . . . . . . . . . . . . . . . . .  25  and  over 2003–2008 
Incisal  trauma. . . . . . . . . . . . . . . . . . . . . . .  10–29 1999–2004 
Orofacial pain exam . . . . . . . . . . . . . . . . . . .  13–69 1999–2004 
Periodontitis. . . . . . . . . . . . . . . . . . . . . . . .  .  .  .  1999–2004 
Gingival bleeding . . . . . . . . . . . . . . . . . . .  12–49 1999–2000 
Loss of attachment . . . . . . . . . . . . . . . . . .  19  and  over 1999–2000 
13 and over 1999–2004 
30 and over 2009–2010 
Periodontal bleeding . . . . . . . . . . . . . . . . . .  13  and  over 2001–2004 
Root  caries  . . . . . . . . . . . . . . . . . . . . . . . .  18  and  over 1999–2004 
Saliva. . . . . . . . . . . . . . . . . . . . . . . . . . . .  40  and  over 1999–2000 
Tooth count . . . . . . . . . . . . . . . . . . . . . . . .  2  and  over 1999–2004 
5 and over 2005–2008 
3–19 and 30 and over 2009–2010 
Tooth  wear  . . . . . . . . . . . . . . . . . . . . . . . .  13  and  over 2003–2004 
. . . Category not applicable. inflammation, a factor in asthma and 
other possible lung diseases. Fractional 
ENO was measured using a biomedical 
device. ENO was performed before 
spirometry because spirometric 
maneuvers have been shown to reduce 
exhaled nitric oxide levels. The ENO 
component was conducted on sample 
participants aged 6–79 for 2007–2010. 
The spirometry component obtained 
data on chronic obstructive pulmonary 
disease, or COPD. Lung function was 
tested to determine the amount and 
speed of air that a person can exhale 
after taking in the deepest possible 
breath. The spirometry component was 
conducted on sample participants aged 
6–79 for 2007–2010. 
Tuberculin skin test 
The tuberculin (TB) skin test 
component obtained data to provide 
information on the extent of tuberculosis 
infection in the United States. Sample 
participants aged 1 and over were tested 
with a TB-purified protein derivative 
(PPD) product, PPD S–1, the standard 
antigen. This component was conducted 
for 1999–2000. 
Vision 
The vision component obtained data 
to measure the prevalence of visual impairment and evaluated functional 
impairment related to vision. This 
component consisted of three parts: 
(a) determination of the prescription of a 
participant’s eyeglasses, if worn; (b) a 
distance visual acuity and objective 
refraction/keratometric evaluation; and 
(c) a vision Near Card test (see also the 
preceding ‘‘Ophthalmology’’ section). 
The vision component was conducted on 
sample participants aged 12 and over for 
1999–2008. 
Interviews in the MEC 
Dietary interview 
The dietary interview component 
obtained detailed dietary intake 
information from sample participants. 
Dietary intake data were used to 
estimate the types and amounts of foods 
and beverages consumed; to estimate 
intakes of energy, nutrients, and 
non-nutrient food components from 
foods and beverages; and to assess 
intake of water. The dietary interview 
comprised three sections: (a) dietary 
recall, (b) nutritional supplement and 
antacid use, and (c) post-recall. This 
component was conducted on sample 
participants of all ages (with proxy, if 
necessary) for 1999–2010. To allow for 
better estimates of usual nutrient intakes to assess diets in the U.S. population, 2 
days of dietary intake data were 
collected for 2002–2010. 
Private health interview 
The private health interview 
consisted of questionnaires addressing 
many health-related topics that were 
sensitive and was conducted in a private 
MEC interview. The interview consisted 
of the computer-assisted personal 
interviewing system (CAPI), the audio 
computer-assisted self-interviewing 
system (ACASI), and the critical data 
items. Sample participants aged 8 and 
over were eligible for the private 
interview. This component was 
conducted for 1999–2010. 
Computer-assisted personal 
interviewing 
The first part of the private health 
interview used CAPI and was conducted 
by a MEC interviewer. Health-related 
questions were asked based on the 
sample participant’s age and gender. 
Table L shows the interview sections for 
the CAPI. All sections of the CAPI 
could be administered using a proxy 
interview or an interpreter if needed. As 
part of the health-related questions, a 
mental health questionnaire was 
administered during 1999–2004. It was 
split into three subsections: (a) the youth 
Computerized Diagnostic Interview 
Schedule for Children (CDISC), (b) the 
parent CDISC, and (c) an NHANES 
version of the World Health 
Organization Composite International 
Diagnostic Interview (CIDI). 
The youth CDISC was administered 
to sample participants aged 8–19 and 
consisted of questions about panic 
disorder, generalized anxiety disorder, 
eating disorders, and depressive 
disorders. The parent CDISC was a 
follow-up and is further mentioned in 
the ‘‘Post-MEC Data Collection’’ 
section. The CIDI was administered to 
sample participants aged 20–39 and 
consisted of a panic disorder, 
generalized anxiety disorder, and 
depressive disorder diagnostic module, 
which addressed diagnoses present in 
the past 12 months. No proxies were 
used during the CIDI. 
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interviewing 
The second part of the private 
interview used an ACASI system. 
Sample participants aged 12–69 were 
given a set of headphones and asked 
sensitive questions (Table L) to which 
they could respond using the touch 
screen. The MEC interviewer was not 
present for the ACASI, and no proxies 
were allowed. 
Critical data items 
The third part of the private 
interview obtained or verified key pieces 
of data about the sample participant. 
Critical data items were important for 
recontacting the sample participant with 
information regarding his or her 
examination or laboratory results. 
Sample participants were verbally asked 
by the MEC interviewer for the correct 
or exact spelling of their name, their 
date of birth, and a correct contact 
telephone number. For more information 
on the private interview, see the 
NHANES website at http://www.cdc. 
gov/nchs/nhanes/participant.htm. 
MEC Biospecimen 
Collection 
NHANES collected biological 
specimens (biospecimens) during MEC 
appointments for analysis in 
laboratories. This included the 
collecting, processing, storing, and 
shipping of blood, urine, and other types 
of specimens. This section provides 
information on all biospecimens 
collected for 1999–2010. 
MEC Laboratory Team 
Each MEC had a laboratory 
containing a bio-hood, complete blood 
count (CBC) and differential analyzer, 
two centrifuges, refrigerators, and 
freezers. Each MEC laboratory team 
included three medical technologists and 
a certified phlebotomist. Staff was 
certified in accordance with guidelines 
set forth by the American Society for 
Clinical Pathology. The medical 
technologists’ tasks included: performing CBCs, pregnancy tests, and 
other tests; processing, storing, and 
shipping specimens; assisting the 
phlebotomist; and printing labels and 
labeling vials. The chief medical 
technologist was the most senior 
member of the laboratory team and was 
responsible for overseeing all laboratory 
activities and performing quality control. 
The phlebotomist’s tasks included: 
administering a questionnaire to screen 
for conditions that excluded sample 
participants from the blood draw, 
determining fasting status, conducting 
the blood draw, administering the 
glucose solution, and conducting a 
second blood draw 2 hours after the 
solution had been administered for the 
oral glucose tolerance test. 
Specific training for laboratory staff 
was dependent upon the position. 
However, all laboratory staff were 
trained thoroughly to ensure that the 
laboratory environment was safe. 
Laboratory staff were aware of 
hazardous chemicals that they worked 
with, familiar with product labels and 
other forms of warning, and 
knowledgeable about how to handle 
accidental exposures. The staff was 
trained annually on each of the 
following: 
+	 Occupational Safety and Health 
Administration (OSHA) Bloodborne 
Pathogen Regulation 
+	 NHANES exposure control plan 
+	 Working safely with hazardous 
chemicals 
+	 Universal precautions and a set of 
guidelines for preventing the 
transmission of bloodborne 
pathogens such as human 
immunodeficiency virus (HIV) and 
hepatitis viruses in health care 
settings. 
Biospecimen Collection 
Biospecimens collected in the MEC 
included blood, hair, nasal swab, oral 
rinse, urine, and vaginal swab. Table M 
lists all laboratory tests conducted for 
1999–2010. Collection procedures 
varied based on the specimen types. 
Laboratories performed more than 545 
different biochemical tests, which 
provided detailed information about the sample participant’s health and 
nutritional status. 
Blood 
Blood was collected from sample 
participants aged 1 and over. The 
phlebotomist used a needle to draw 
blood from a vein in the antecubital 
fossa of the participant’s arm. The 
amount of blood drawn varied by age 
and survey year, but was not more than 
128 mL for participants aged 12 and 
over. Blood was processed and aliquoted 
into vials for storage in the MEC. The 
vials were then refrigerated or frozen 
before transport to laboratories across 
the United States. Most assays were 
completed in remote laboratories, except 
for the CBC and pregnancy tests, which 
were done in the MEC. If permission 
was granted, some specimens were 
aliquoted into vessels and banked for 
future studies, including genetic studies. 
If excess serum remained after tests at 
remote laboratories were completed, it 
was shipped back to the NHANES 
biorepositories and stored for future 
research. This component was conducted 
for 1999–2010. 
Hair 
A sample of hair was obtained and 
analyzed for total mercury level. This 
procedure consisted of the health 
technician collecting approximately 100 
strands from male and female sample 
participants aged 1–5, and from females 
aged 16–49. This component was 
conducted for 1999–2001. 
Nasal swab 
A nasal swab was done to 
understand the extent of Staphylococcus 
aureus nasal colonization, including the 
prevalence of methicillin-resistant 
Staphylococcus aureus, or MRSA, 
colonization. This procedure consisted 
of the health technician inserting the 
swab 2 cm into the nostril and rotating 
for 3 seconds, then repeating the 
procedure in the other nostril. This 
component was conducted on sample 
participants aged 1 and over for 
2001–2004. 
Table L. Mobile examination center interviews: National Health and Nutrition Examination Survey, 1999–2010 
Interview component and section Description Survey years 
Computer-assisted personal 
interviewing system 
Alcohol use . . . . . . . . . . . . . . . . .  
Bowel health . . . . . . . . . . . . . . . .  
Current health status . . . . . . . . . . .  
Depression screener . . . . . . . . . . .  
Dietary screener module . . . . . . . . . 
  
Kidney conditions . . . . . . . . . . . . . 
  
Pesticide exposure . . . . . . . . . . . . 
  
Physical activity . . . . . . . . . . . . . . 
  
Prostate conditions . . . . . . . . . . . . 
  
Reproductive health. . . . . . . . . . . . 
  
Respondent information . . . . . . . . . 
  
Tobacco use . . . . . . . . . . . . . . . . 
  
Volatile toxicants. . . . . . . . . . . . . . 
  
Weight history  . . . . . . . . . . . . . . . 
  
Audio computer-assisted personal
 
interviewing system
 
Alcohol . . . . . . . . . . . . . . . . . . . 
  
Drug use  . . . . . . . . . . . . . . . . . . 
  
Food security. . . . . . . . . . . . . . . . 
  
Prostate conditions . . . . . . . . . . . . 
  
Sexual behavior . . . . . . . . . . . . . . 
  
Tobacco use . . . . . . . . . . . . . . . . 
  
Youth conduct disorder . . . . . . . . . . 
  
Dietary
 
Dietary recall . . . . . . . . . . . . . . . . 
  
Dietary supplement . . . . . . . . . . . . 
  
Lifetime  and  current  use  (past 12 months) 1999–2010 
Fecal incontinence and defecating function 2005–2010 
Overall  health assessment, quality of life (past 30 days), recent illness (past 30 days), blood donation, and HIV testing 1999–2010 
Depression symptoms and impairment from depression symptoms; depression measured using the Patient Health Questionnaire 2005–2010 
(PHQ-9), a nine-item screening instrument that asks questions about the frequency of symptoms of depression over the past 2 weeks, 
with a final follow-up question to assess overall impairment from depressive symptoms. Response categories ‘‘not at all,’’ several days,’’ 
more than half the days,’’ and ‘‘nearly every day’’ were scored 0–3; a total score was calculated at 0–27. A score of 10 or higher has 
been well-validated and commonly used in clinical studies to define depression; other methods for defining depression based on this 
instrument were also used 
Food and drink consumed in the home, restaurants, and other locations in past 30 days 2009–2010 
Kidney disease, kidney stones, urinary incontinence, and nocturia 1999–2010 
Pesticide  use  in  the  home  and  lawn  or  garden  during  the  past 7 days 2005–2010 
Daily  activities,  leisure-time  activities,  and  sedentary activities 1999–2010 
Prostate  conditions and whether a rectal examination had been done to check for prostate cancer 2005–2008 
Menstrual history, pregnancy history, lactation, oral contraceptive and hormone replacement therapy use, and other related conditions 1999–2010 
Identified relationship of respondent to sample participant; also identified why sample participant could not respond (proxy), and gave 1999–2010 
information on the use of interpreters and language used for the interview 
Use  of  cigarettes,  pipes, cigars, and other forms of tobacco, as well as nicotine replacement therapies (e.g., nicotine patches), in the past 1999–2010 
5 days 
Exposure to chemicals that are on priority toxicant or critical contaminant lists 2005–2010 
Self-perception of weight, reasons for losing weight, and methods used to lose weight 2005–2010 
Lifetime  and  current  use  (past 12 months); questions not specific to type of alcohol used 1999–2010 
Lifetime  and  current  use  of  cocaine and other street drugs and intravenous use of illicit drugs 1999–2010 
Household food security, individual food security, food stamp program benefits, and Women, Infants and Children program benefits 2005–2010 
Prostate  conditions, prostate cancer treatment, and erectile dysfunction 2001–2004 
Lifetime  and  current  sexual behavior for both men and women; major items included age at first sexual intercourse, number of sexual 1999–2010 
partners, sexual orientation, circumcision status (men), and history of sexually transmitted diseases 
Cigarette  use, including history of use, age at initiation, current use, past 30-day prevalence, amount, cigarette brand, and other related 1999–2010 
details 
Comprises  eight  questions from the Diagnostic Interview Schedule for Children Predictive Scales (DPS) developed by the Columbia 1999–2004 
University College of Physicians and Surgeons/New York State Psychiatric Institute in New York, N.Y., and focused only on those items 
from the full Conduct Disorder module considered significant predictors of disorder; shown to determine adolescents who are at high 
probability of meeting diagnostic criteria accurately 
Detailed  dietary  intake  information  to  estimate  types and amounts of foods and beverages (including all types of water) consumed during 1999–2010 
the 24-hour period prior to the interview (midnight to midnight), and to estimate intakes of energy, nutrients, and other food components 
from those foods and beverages; following dietary recall, participants were asked questions on salt use, whether respondent is on any 
type of special diet, frequency of fish and shellfish consumed during the past 30 days, and whether overall intake on the previous day 
was much more than usual, usual, or much less than usual 
Types and amounts of dietary supplements consumed during the 24-hour period prior to the interview (midnight to midnight) 2007–2010 
S
e
r
i
e
s
 
1
,
 
N
o
.
 
5
6
 
[
 
P
a
g
e
 
1
7
 
Table M. Laboratory tests: National Health and Nutrition Examination Survey, 1999–2010 
Analyte Specimen Description Survey years 
Acrylamide/Glycidamide  . . . . . . . . . . . . . . . . . . . . . . . . . .  Whole  blood  Chemical  carcinogen used in synthetic fibers 2003–2010 
Albumin  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Urine  Major  protein  in  the  body 1999–2010 
Albumin/Creatinine  ratio  . . . . . . . . . . . . . . . . . . . . . . . . . .  Urine  Ratio  of  albumin  to  creatinine  used to detect kidney disease progression 2009–2010 
Allergen total and specific IgE immunoglobulins . . . . . . . . . . .  Serum  Markers  of  immune  response to allergens 2005–2006 
Apolipoprotein (B). . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Protein  that  binds  to  lipids  and  transports them in the body 2005–2010 
Arsenic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Urine  Toxic  heavy metal 2003–2010 
Arsenic (total/speciated) . . . . . . . . . . . . . . . . . . . . . . . . . .  Urine  Toxic  heavy metal 2007–2010 
Bacterial vaginosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Swab  Imbalance in bacteria normally found in the vagina 2001–2004 
Biochemistry panel . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Panel of 23 clinical tests used to assess general health 1999–2010 
Bone alkaline phosphatase . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Enzyme that removes phosphate from other molecules 1999–2004 
Cadmium (blood) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Whole  blood  Toxic  heavy metal 1999–2010 
Caffeine  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Urine  Psychoactive stimulant 2009–2010 
CD4/CD8  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Whole  blood  Cells  that  protect  the  body from infection 1999–2006 
Chlamydia  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Urine  Sexually transmitted pathogen 1999–2010 
Complete blood count . . . . . . . . . . . . . . . . . . . . . . . . . . .  Whole  blood  Panel of 20 clinical tests used to assess general health 1999–2010 
Cotinine  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Metabolite of nicotine 1999–2010 
C-peptide  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Protein  marker  of  insulin secretion 1999–2004 
C-reactive protein . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Protein  produced in response to tissue damage and inflammation 1999–2010 
Creatinine. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Urine/serum  Waste  product of normal muscle breakdown 1999–2010 
Cryptosporidium (antibody) . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Intestinal  parasite  usually found in water 1999–2001 
Current-use pesticides/Priority pesticides . . . . . . . . . . . . . . .  Urine/serum  Chemicals  that  repel or destroy pests (insects and rodents) 1999–2010 
Fungicides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Urine/serum  Chemicals  that  destroy fungi 1999–2010 
Herbicides  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Urine/serum  Chemicals  that  destroy plants 1999–2010 
Dioxins, furans, and coplanar PCBs/Persistent pesticides . . . . .  Serum  Synthetic  chemicals that persist as environmental pollutants 1999–2010 
Endotoxins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Dust  Toxins  associated with certain bacteria 2005–2006 
Environmental pesticides/Halogenated phenolic compounds. . . .  Urine  Chemicals  that  repel or destroy pests (insects and rodents) 1999–2010 
Environmental phenols. . . . . . . . . . . . . . . . . . . . . . . . . . .  Urine  Natural  and  synthetic chemicals containing phenol that may be toxic 1999–2010 
Environmental parabens . . . . . . . . . . . . . . . . . . . . . . . . . .  Urine  Synthetic  preservatives that may cause hormone disruption 2005–2010 
Erythrocyte protoporphyrin . . . . . . . . . . . . . . . . . . . . . . . .  Whole  blood  Protein  used in the synthesis of hemoglobin in the red blood cell 1999–2006 
Fatty  acids  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Plasma  Synthetic  fat  found in food that raises LDL cholesterol and lowers HDL cholesterol 2007–2010 
Ferritin. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Iron  stored  in  the  body 1999–2010 
Fibrinogen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Plasma  Coagulation protein 1999–2002 
Flow  rate  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Urine  Measure of urine quantity produced in a specified time period 2009–2010 
Folate (RBC) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Whole  blood  Vitamin  important  in  the  formation  of  red  blood  cells  1999–2010 
Folate  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Vitamin  important  in  the  formation  of  red  blood  cells  1999–2010 
Follicle stimulating hormone/LH . . . . . . . . . . . . . . . . . . . . .  Serum  Hormone  that  regulates ovarian function 1999–2002 
Glucose plasma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Plasma  Amount of sugar in the blood 1999–2010 
Glycohemoglobin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Whole  blood  Measure of average blood glucose in the past 2 to 3 months 1999–2010 
Gonorrhea  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Urine  Sexually transmitted disease pathogen 1999–2008 
Helicobacter pylori . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Bacterium  that  causes stomach ulcers 1999–2001 
Hepatitis B anti-HBs . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Indicates  previous  exposure to hepatitis B infection, or vaccination 1999–2010 
Hepatitis B HBsAg . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Indicates  hepatitis B infection 1999–2010 
Hepatitis A, C, and D (antibody) . . . . . . . . . . . . . . . . . . . . .  Serum  Serologic  tests  for  antibody to viruses that cause liver disease 1999–2010 
Hepatitis C RNA (HCU–RNA) and HCV genotype . . . . . . . . . .  Serum  Serologic  tests  to  identify Hepatitis C RNA and genotypes 2007–2010 
Hepatitis E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Serologic  tests  to  identify Hepatitis C RNA and genotypes 2009–2010 
Herpes 1 and 2 antibody . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Antibodies to herpes virus 1999–2010 
Herpes 1 and 2 antibody . . . . . . . . . . . . . . . . . . . . . . . . .  Urine  Antibodies to herpes virus 1999–2010 
HIV antibody . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Antibody to HIV 1999–2010 
HLA–B27  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Antigen  found in blood associated with a number of inflammatory conditions 2009 only 
Homocysteine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Plasma  Amino  acid  in  the  blood  that  can  be  a  risk  factor  for  cardiovascular disease 1999–2006 
Human papillomavirus . . . . . . . . . . . . . . . . . . . . . . . . . . .  Oral  rinse  Virus  that  infects  the  skin  and  may  cause cancer 2009–2010 
Human papillomavirus . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Virus  that  infects  the  skin  and  may  cause cancer 2002–2010 
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Table M. Laboratory tests: National Health and Nutrition Examination Survey, 1999–2010—Con. 
Analyte Specimen Description Survey years 
Human papillomavirus . . . . . . . . . . . . . . . . . . . . . . . . . . .  Swab  Virus  that  infects  the  skin  and  may  cause cancer 2002–2010 
Indoor allergens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Dust  Any  substance found in the bed or bedroom that can cause an allergic reaction 2005–2006 
Insulin  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Hormone  that  regulates glucose metabolism 1999–2010 
Iodine  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Urine  Element  that  is  a  component of thyroid hormones 2000–2010 
Iron. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Mineral  the  body needs to make red blood cells 1999–2006 
Latex  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Natural  or  synthetic emulsion of polymer microparticles 1999–2001 
Lead . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Whole  blood  Toxic  metal  that  can  affect  physical and mental development 1999–2010 
Lead dust . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Dust  Lead that is recovered from household dust 1999–2004 
Total cholesterol, triglycerides, HDL, LDL . . . . . . . . . . . . . . .  Serum  Lipid  panel showing concentrations of lipids in the blood 1999–2010 
Lipoprotein a (Lpa) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Low-density lipoprotein that is a risk factor for atherosclerotic disease 2005 only 
Measles/Rubella/Varicella (antibody) . . . . . . . . . . . . . . . . . .  Serum  Markers  of  immunization  status  1999–2004 
Measles/Mumps/Varicella/Rubella (antibody) . . . . . . . . . . . . .  Serum  Markers  of  immunization  status  2009–2010 
Mercury  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Whole  blood  Toxic  heavy metal 1999–2010 
Mercury  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Hair  Toxic  heavy metal 1999–2001 
Mercury  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Urine  Toxic  heavy metal 1999–2010 
Methylmalonic  acid  . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Plasma  Elevated levels may indicate Vitamin B12 deficiency 1999–2004 
MRSA  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Swab  Methicillin-resistant Staphylococcus aureus (a bacteria resistant to the antibiotic methicillin) 2001–2004 
Multi-element metals/heavy metals . . . . . . . . . . . . . . . . . . .  Urine  Toxic  heavy metals detected in urine 1999–2010 
NNAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Urine  Metabolite of nicotine 2007–2010 
NTX (N-telopeptides) . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Urine  Breakdown product of collagen, used as a marker of bone turnover 1999–2002 
OGTT glucose plasma . . . . . . . . . . . . . . . . . . . . . . . . . . .  Plasma  Oral  glucose tolerance test to determine how quickly glucose is cleared from the blood 2005–2010 
Omega-3 fatty acids/PUFA . . . . . . . . . . . . . . . . . . . . . . . .  Plasma  Polyunsaturated fat found in food, which has been shown to lower the risk of cardiovascular 2007–2010 
disease 
Organochlorine pesticides . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Diverse  synthetic insecticides that are persistent in the environment 1999–2010 
Organophosphate insecticides . . . . . . . . . . . . . . . . . . . . . .  Urine  Diverse  synthetic insecticides that are persistent in the environment 1999–2010 
Osmolality  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Urine  Measure of urine concentration 2009–2010 
Parathyroid  hormone  . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Hormone  that  regulates calcium absorption and converts vitamin D to its active form 2003–2006 
Perchlorate  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Urine  Chemical  that  interferes  with  iodine  uptake  by  the  thyroid  gland  2005–2010 
Perchlorate,  nitrate,  and  iodine. . . . . . . . . . . . . . . . . . . . . .  Water  Three  toxicologically  related  analytes that affect thyroid function 2005–2008 
Perchlorate, nitrate, and thiocyanate . . . . . . . . . . . . . . . . . .  Urine  Nitrate  is  a  component of fertilizer that is a groundwater pollutant; thiocyanate is a compound 2007–2010 
in tobacco smoke 
Phthalates  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Urine  Chemicals  used in plastic that have been shown to change hormone levels 1999–2010 
Phytoestrogens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Urine  Naturally  occurring nonsteroidal plant compounds that are similar to estrogen 1999–2010 
Polycyclic aromatic hydrocarbons (PAH) . . . . . . . . . . . . . . . .  Urine  Atmospheric pollutants produced as byproducts of burning fuel 1999–2010 
Polybrominated diphenl ethers (BDEs) . . . . . . . . . . . . . . . . .  Serum  Flame  retardants that bio-accumulate and may cause hormone-disrupting effects 2003–2010 
Polyfluorinated compounds . . . . . . . . . . . . . . . . . . . . . . .  Serum  Persistent  organic pollutants 2003–2010 
Pregnancy (HCG) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Urine  Hormone  diagnostic for pregnancy 1999–2010 
PSA  (free/total)  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Protein  produced by the prostate gland that is elevated in prostate conditions 2001–2010 
PSA  (complex). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Prostate-specific antigen complexed to proteins 2007–2010 
Selenium  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Essential micronutrient that catalyzes enzyme reactions 1999–2004 
Surplus  sera  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum/urine/plasma  Residual sera used for special studies 1999–2010 
SRM pesticides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Selected  reaction monitoring (SRM) is a method of chromatography resulting in highly specific 2003–2010 
quantification of analyte 
Syphilis IgG, RR, and TP–PA. . . . . . . . . . . . . . . . . . . . . . .  Serum  Tests  that  detect  syphilis, a sexually transmitted pathogen 2001–2004 
Thyroid function testing (T4, TSH). . . . . . . . . . . . . . . . . . . .  Serum  Tests  to  assess thyroid function 1999–2002 
Thyroid function testing (T4, T3, ATG,TGN, APO, TSH). . . . . . . Serum Tests to assess thyroid function 2005–2010 
TIBC  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Test  that  determines  iron-binding  capacity 1999–2006 
Toxoplasma (IgG and IgM) . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Antibodies to a parasite that can cause illness in humans 1999–2004 
Transferrin receptor. . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Carrier  protein  for  transferrin 2003–2010 
Transferrin saturation. . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Ratio  of  serum  iron  and  total  iron-binding  capacity, multiplied by 100 1999–2006 
Trichomonos (females). . . . . . . . . . . . . . . . . . . . . . . . . . .  Swab  Parasite  that  causes vaginal infection 2001–2004 
Tissue transglutaminase and endomysial antibodies . . . . . . . .  Serum  Markers  of  celiac  disease 2009–2010 
Vitamins A and E/Carotenoids . . . . . . . . . . . . . . . . . . . . . .  Serum  Nutrient  vitamins  required for retinal function that act as antioxidants 1999–2006 
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Table M. Laboratory tests: National Health and Nutrition Examination Survey, 1999–2010—Con. 
Analyte Specimen Description Survey years 
Vitamin  B6  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Part  of  the  vitamin  B-complex  that  acts  as  an  enzyme cofactor in amino acid metabolism 2003–2010 
Vitamin  B12  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Part  of  the  vitamin  B-complex  involved in cell metabolism and DNA synthesis 1999–2006 
Vitamin  C  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Nutrient  vitamin  that  acts  as  an  enzyme cofactor and antioxidant 2001–2006 
Vitamin  D  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Serum  Nutrient  vitamin  produced in the skin after absorption of ultraviolet light 1999–2010 
VOC (blood) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Whole  blood  Toxic  volatile  organic compounds 1999–2010 
VOC exposure monitor. . . . . . . . . . . . . . . . . . . . . . . . . . .  Air  monitor  Measures environmental exposure to toxic volatile organic compounds 1999–2001 
VOC  (water)  .  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Water  Toxic  volatile  organic compounds found in residential water 1999–2010 
WBC/DNA  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Whole  blood  White  blood  cells  used to extract DNA 1999–2002, 
2007–2010 
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An oral rinse was collected and 
tested for the presence of multiple types 
of human papillomavirus (HPV). The 
examining dentist instructed sample 
participants aged 14–69 to gargle with 
mouthwash for 30 seconds and then spit 
into a specimen container. This 
component was conducted for 
2009–2010. 
Urine 
Urine was collected for the 
following purposes: (a) to do a urine 
pregnancy test on female participants 
aged 12–59 and menstruating females 
aged 8–11, (b) to aliquot, store, and 
transport to multiple laboratories for 
analysis, (c) to aliquot and bank for 
future studies, and (d) to do a backup 
HIV test if the amount of blood 
collected was insufficient for HIV 
testing. Participants aged 6 and over 
were asked to provide random urine by 
voiding into specimen cups. The amount 
collected varied. This component was 
conducted for 1999–2010. 
Vaginal swab 
Female participants aged 14–59 
were asked to self-collect a vaginal 
specimen using a sterile swab. The 
vaginal swab was tested for the presence 
of multiple types of HPV. In privacy, the 
participant inserted the swab and turned 
the foam tip against the walls of the 
vagina while counting to 10. The swab 
was removed without touching the skin 
or hair outside of the vagina and placed 
back into its original container. This 
component was conducted for 
2002–2010. 
Oral Glucose Tolerance 
Test 
The oral glucose tolerance test 
(OGTT) was conducted on sample 
participants aged 12 and over who were 
examined in the morning session and 
had completed at least a 9-hour fast. 
After the initial blood draw, participants 
were asked to drink 75 grams of 
dextrose (10 oz. of glucose solution) 
within 10 minutes. Two hours later, a second blood sample was drawn. The 
inclusion of OGTT provided information 
on the extent of impaired glucose 
tolerance, or IGT, and diabetes in the 
U.S. population. This component was 
conducted for 2005–2010. 
Biospecimen Processing 
and Shipping 
Specimens were labeled with a 
number that corresponded to the 
participant’s sample number. Labels 
were generated and affixed to vials. This 
allowed for tracking specimens from 
MEC processing through receipt in the 
contract laboratory. All vials were 
secured to prevent leakage and 
evaporation. Specimen processing 
varied. For example, blood processing 
included centrifuging and storing blood 
collection tubes; aliquoting whole blood 
into vials; centrifuging, separating, and 
aliquoting plasma and serum into vials; 
performing dilutions; and washing and 
lysing, or deconstructing, whole blood 
cells. All specimens were immediately 
stored at –20°C or refrigerated at 
4°–8°C. Once processed, specimens 
were shipped to a variety of contract 
laboratories. Wet or dry ice was used if 
necessary for shipping. Each shipment 
included a copy of a shipping manifest. 
Most specimens were packed and 
shipped once a week. 
Quality Assurance and 
Quality Control 
The NHANES MEC laboratory was a 
Clinical Laboratory Improvement Act-
certified laboratory of moderate complexity. 
Quality assurance and quality control 
(QA/QC) involved both internal and 
external surveillance. QA/QC procedures 
were performed in the MEC as well as in 
contract laboratories. As part of the overall 
QA process, all collection materials, 
vacuum sample vials, and storage 
containers used were initially prescreened 
for background contamination levels of 
blood lead, cadmium, and mercury; and 
urinary heavy metals, arsenic, iodine, and 
mercury. EDTA (ethylenediaminetetraacetic 
acid) tubes were used after prescreening 
confirmed that they had no contamination. 
The lot number and expiration dates for all vacuum sample vials, needles, and reagents 
were recorded. 
Specific QC procedures were 
followed in the laboratory as well. For 
example, the freezers, refrigerators, and 
centrifuges were cleaned before the 
MEC opened, and a temperature reading 
on these items was conducted daily. 
On-site calibrations were performed 
twice each year. The NCHS biomedical 
engineer certified the revolutions per 
minute (rpm) of the centrifuges 
periodically and replaced the high-
efficiency particulate air (HEPA) filters 
as necessary. All instrument maintenance 
was recorded. NHANES laboratories 
participated in the College of American 
Pathologists (CAP) proficiency-testing 
program. CAP samples were sent three 
times a year for the CBC and qualitative 
serum human chorionic gonadotropin 
(hCG). In addition, blind split samples 
were used for QC determinations. 
Contract laboratories followed their 
QA/QC guidelines when working with 
NHANES specimens. However, to 
ensure QA/QC, NHANES staff 
conducted annual laboratory inspections 
and reviewed the QC data from each 
laboratory. 
Post-MEC Data 
Collection 
At the conclusion of their MEC 
appointment, sample participants were 
recruited to participate in post-MEC 
data collection activities (Table N). 
Eligibility for post-MEC data collection 
depended on the sample participant’s 
age and gender and whether he or she 
completed the required components. 
Sample participants who also 
participated in any of the post-MEC 
data collection activities received 
additional remuneration, summarized in 
Table N. 
Post-MEC data collection activities 
for 1999–2010 included: 
+	 Allergen dust collection 
+	 Dietary telephone follow-up 
+	 Flexible consumer behavior survey 
(FCBS) 
+	 Food frequency questionnaire 
+	 Hepatitis C follow-up questionnaire 
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Table N. Post-MEC examinations: National Health and Nutrition Examination Survey, 
1999–2010 
Component name	 Survey years Remuneration amount 
Allergen dust collection . . . . . . . . . . . . . . 
  
Dietary phone follow-up . . . . . . . . . . . . . . 
  
Flexible consumer behavior survey . . . . . . . 
  
Food frequency . . . . . . . . . . . . . . . . . . . 
  
Hepatitis C follow-up . . . . . . . . . . . . . . . . 
  
Home urine collection  . . . . . . . . . . . . . . . 
  
Parent composite international diagnostic
 
interview  . . . . . . . . . . . . . . . . . . . . . . 
  
Physical activity monitor . . . . . . . . . . . . . . 
  
Prostate-specific antigen follow-up . . . . . . . 
  
Tuberculin skin test . . . . . . . . . . . . . . . . . 
  
VOC exposure monitor. . . . . . . . . . . . . . . 
  
2005–2006 $50 per family 
2002–2010 $30 per participant 
2007–2010 $15 per participant 
2003–2006 $30 per participant 
2001–2010 – 
2009–2010 $40 per participant 
2000–2004 $30 per participant 
2003–2006 $40 per participant 
2003–2006 – 
1999–2000 $30 per participant 
1999–2001 $15 per participant 
– Quantity zero.
 
NOTES: MEC is mobile examination center. VOC is volatile organic compound.
 +	 Home urine collection 
+	 Parent interview of the computer 
diagnostic interview schedule for 
children (CDISC) 
+	 Physical activity monitor (PAM) 
+	 Prostate-specific antigen, or PSA, 
follow-up questionnaire 
+	 Tuberculin (TB) skin test reading 
+	 Volatile organic compound (VOC) 
exposure monitor 
Allergen Dust Collection 
The allergen dust collection 
component collected bed and floor dust 
samples to obtain data on allergens and 
endotoxins. All households that had 
sample participants aged 1 and over 
who completed the MEC examination 
were eligible. This component was 
collected for 2005–2006. 
Dietary Interview 
Follow-up 
To obtain a more complete picture 
of the usual dietary intake of the U.S. 
population, a second 24-hour dietary 
interview of participants was done by 
telephone. This questionnaire took 
approximately 30–40 minutes and was 
conducted 3–10 days after the sample 
participant’s MEC exam. All sample 
participants aged 1 and over who 
completed the MEC dietary interview 
were eligible to participate. Proxy 
interviews were conducted for children 
aged 1–11. This interview was 
conducted for 2002–2010. 
Flexible Consumer 
Behavior Survey 
The FCBS was a 15-minute 
telephone interview that collected 
information on the sample participant’s 
knowledge, attitude, and beliefs 
regarding food nutrition and food 
choices. All sample participants were 
eligible if they completed the first part 
of the FCBS during the household 
interview, and the dietary interview in 
the MEC. This interview was conducted 
for 2007–2010. Food Frequency 
Questionnaire 
The food frequency questionnaire 
collected information on how often 
certain foods were consumed. The 
questionnaire was sent by mail to 
examined sample participants aged 2 
and over and took approximately 20–30 
minutes to complete. This questionnaire 
was used for 2003–2006. 
Hepatitis C Follow-up 
The hepatitis C follow-up was a 
telephone questionnaire conducted on 
sample participants who tested positive 
for hepatitis C, to obtain information on 
their knowledge about their infection 
and follow-up after notification. The 
hepatitis C follow-up took place 6 
months after the NHANES examination 
and was approximately 20 minutes in 
duration. There was no remuneration for 
participation. This questionnaire was 
used for 2001–2010. 
Home Urine Collection 
The home urine collection was done 
within 10 days of a sample participant’s 
MEC exam. Sample participants aged 6 
and over were eligible. The first 
morning void was collected in a 
collection cup provided to the sample 
participant. The specimen was mailed to 
the laboratory for analysis. See the 
preceding section on ‘‘MEC 
Biospecimen Collection’’ for more 
information on the NHANES laboratory. This component was collected for 
2009–2010. 
Parent Interview of 
Computerized Diagnostic 
Interview Schedule for 
Children 
The parent interview of the CDISC 
was a telephone follow-up for the parent 
or guardian of select children, aged 
8–15, who participated in the CDISC in 
the MEC. The parent interview of the 
CDISC took approximately 30 minutes 
depending on the case. The parent 
interview was conducted 4–28 days after 
the child’s MEC exam. This interview 
was conducted for 2000–2004. 
Physical Activity Monitor 
The PAM component was 
conducted to assess physical activity 
levels for sample participants aged 6 
and over. Sample participants were 
asked to wear the PAM for 7 days. After 
the 7 days, the sample participant 
mailed the PAM to the contractor home 
office. This component was conducted 
for 2003–2006. 
Prostate-specific Antigen 
The PSA follow-up was a telephone 
questionnaire conducted on men with 
high PSA test results, to obtain 
information on their knowledge of PSA 
and follow-up after notification. The 
PSA follow-up took place 6 months 
after the NHANES examination and was 
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There was no remuneration for 
participation. This questionnaire was 
asked for 2003–2006. 
Tuberculin Skin Test 
Reading 
The TB skin test required a 
follow-up appointment to measure the 
reaction. The test measurement took 
place 46–54 hours after the antigen was 
placed under the skin of sample 
participants aged 1 and over. This 
reading was conducted for 1999–2000. 
Volatile Organic 
Compound Exposure 
Monitor 
The VOC exposure monitor data 
were collected to measure environmental 
exposure to toxic VOCs. Selected 
sample participants aged 20–59 wore 
small, lightweight passive sampling 
badges for 48 hours, beginning once 
they left the MEC. Sample participants 
returned with the badge and a sample of 
tap water from their homes. They also 
had a second blood draw when they 
returned the monitor and the water 
sample. This component was conducted 
for 1999–2001. 
Report of Findings 
Health measurements and laboratory 
test results were provided to all sample 
participants who completed the MEC 
exam. The NHANES Physician 
Advisory Group determined which 
results should be reported back to 
participants, and how this should be 
done. Reporting protocols were 
reviewed and approved by the NCHS 
Research Ethics Review Board (ERB); 
for more information on the ERB, see 
the ‘‘Ethical, Privacy, and 
Confidentiality Considerations’’ section. 
The reports provided to sample 
participants were called Reports of 
Findings. 
A preliminary Report of Findings 
was given to participants at the 
conclusion of their MEC exam. This preliminary report included a letter of 
gratitude and all examination results that 
could be recorded in the MEC. 
Examples of such results included blood 
pressure, height and weight, and a 
complete blood count (CBC). 
If abnormal findings were 
discovered during a MEC examination, 
the physician discussed these findings 
with the sample participant. The 
physician also made referrals if 
necessary. In general, there were three 
levels of examination findings and 
associated referrals. 
Level I Finding 
(Emergency) 
A Level I finding was a medical 
emergency, for example, a dangerously 
high systolic blood pressure or seizure. 
The MEC physician managed medical 
emergencies. An emergency medical kit 
was available in each MEC so that 
emergency stabilization could be 
performed. However, the preferred 
method of handling medical 
emergencies was to contact local rescue 
squads, ambulance services, and hospital 
emergency rooms. The telephone 
numbers for local emergency services 
were posted in the MEC. A Level I 
finding was rare. 
Level II Finding (Early 
Report) 
A Level II finding required the 
participant to follow up with his or her 
regular doctor within 2 weeks. These 
findings were detected either at the 
MEC or after the examination when 
laboratory results were sent from the 
laboratories. The MEC physician 
evaluated these findings, such as an 
abnormality in the CBC, and counseled 
sample participants before they left the 
examination center. The physician also 
provided the sample participant with a 
written report of the condition and urged 
the participant to make an appointment 
with his or her primary care physician 
within the next 2 weeks. If the 
participant had no primary care 
physician, the MEC physician had 
access to a list of providers or clinics 
where the participant could be evaluated at no charge, or on a sliding-scale fee 
schedule. 
Level II findings also occurred 
when a laboratory or contractor 
discovered abnormalities based on 
NHANES early reporting thresholds. 
Laboratories transmitted results that met 
the threshold for early reporting 
immediately by uploading results to a 
secure FTP site or e-mailing the results 
for import. Once abnormal findings 
were received, an early reporting letter 
describing the finding was sent to the 
sample participant (or parent, if a 
minor), urging the participant to see a 
medical provider for evaluation. The 
participant also had the option to talk 
with the DHANES medical officer. This 
type of Level II referral usually 
occurred within 3 weeks after the 
examination. Again, it was 
recommended that the participant follow 
up with his or her regular doctor within 
2 weeks of receiving the early report 
with laboratory abnormalities. 
Level III Finding (Routine) 
A Level III finding was the routine 
Report of Findings (i.e., the Final 
Report of Findings) provided to all 
sample participants approximately 3–4 
months after their examination date. 
This report was mailed to sample 
participants and included a letter of 
gratitude, all final examination results, 
and a laboratory glossary that helped 
participants to understand their blood 
results. Contact information for a 
DHANES medical officer was also 
provided should the participant have 
questions. 
Reporting Procedures for 
Minors 
The procedure to report results to 
minors was similar to that for reporting 
results to adult sample participants. If a 
parent or guardian accompanied a minor 
to the MEC, the preliminary Report of 
Findings was given to the parent or 
guardian. Any abnormal findings were 
communicated to the parent or guardian, 
and when applicable, NHANES staff 
requested permission from the parent or 
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care physician. 
If a parent or guardian did not 
accompany a minor to the MEC, and if 
there were any abnormal results, 
NHANES notified the parent or 
guardian as follows: 
+	 For a Level I finding, the MEC 
physician immediately called the 
parent or guardian. 
+	 For a Level II referral, the MEC 
physician called the parent or 
guardian to inform him or her and 
to obtain consent to notify the 
minor’s primary care physician. The 
MEC physician also gave the parent 
or guardian a list of providers in the 
area who could assist in evaluation 
and treatment. 
Reporting Procedures for 
Sexually Transmitted 
Diseases and HIV 
The reporting of sexually 
transmitted diseases (STDs) and HIV 
test results was handled differently from 
other NHANES examination findings. 
STD and HIV test results were provided 
to sample participants by telephone. 
Because of the medical, social, and 
emotional consequences of positive STD 
and HIV tests, disclosure of results was 
handled such that counseling was 
provided at the time results were given. 
At the time of the MEC 
examination, the physician provided 
STD and HIV pretest counseling. The 
physician explained the purpose of the 
testing, the reporting procedures, and the 
confidentiality assurances. The 
participant could decline the STD or 
HIV testing at this point. 
If the sample participant agreed to 
the STD and HIV testing, the physician 
asked the sample participant to provide 
a password to be used when results 
were given later. This password was 
entered into the database. Before leaving 
the MEC, sample participants were 
given a paper with a toll-free number, 
their password, and the date after which 
their test results were available 
(approximately 3–4 weeks after the 
examination). The sample participant was instructed not to share the 
information with anyone and to call for 
the test results after the stated date. 
Adolescents aged 14–17 were 
instructed to call for their results the 
same way as adults. Results, whether 
positive or negative, were given to the 
sample participant over the telephone 
after the sample participant provided the 
DHANES STD and HIV counselor with 
a password. Adolescents who did not 
call for their findings within a 10-day 
period of the designated dates were 
notified by telephone. Three attempts 
were made to contact the adolescent. 
Adults who did not call for their 
findings within a 10-day period of the 
designated dates were sent a reminder 
letter from DHANES. If the adult 
sample participants did not call within a 
10-day period after the reminder letter 
was sent, a second notification letter 
was sent again reminding them to call 
DHANES to get their test results. If 
there was no response after 10 days 
from the second mailing, a third and 
final letter was sent. 
Results of STD or HIV tests were 
not put in writing with the sample 
participant’s name or any other personal 
identifiers, unless the participant 
requested that the findings be mailed to 
them. STD results, including HIV, were 
given in both English and Spanish. 
DHANES staff who provided results 
completed a 3-day course on sexually 
transmitted infections and were HIV 
counseling certified. 
Data Processing and 
Information 
Technology 
Information technology (IT) played 
a vital role in the success of NHANES. 
The vision for NHANES 1999–2010 
was to automate as much of the data 
collection as possible. Objectives 
included verification of data, utilization 
of common data elements across 
components and cycles, reduction of 
burden on the participant, and minimal 
post-data collection editing. The requirements for automation were to: 
+	 Maintain an audit trail for data and 
systems modifications. 
+	 Ensure configuration management in 
the form of version control over all 
applications. 
+	 Allow for maximum use of 
commercial off-the-shelf, or COTS, 
equipment and software. 
+	 Produce formatted and structured 
documentation available online. 
+	 Permit a graphical user interface and 
point of entry validation. 
+	 Ensure a flexible system structure. 
+	 Develop systems compatible with 
Microsoft Windows. 
+	 Design security functions into all 
system processes. 
+	 Permit the timely delivery of data 
from the point of origin to secure 
storage. 
Architecture 
In 1999, NHANES developed the 
Integrated Survey Information System 
(ISIS), a comprehensive architecture for 
data collection. Since ISIS was 
introduced, automated data collection 
and reporting of interview, examination, 
and laboratory data has been completed 
for 177 NHANES sites across the 
United States. ISIS included a private 
wide area network, or WAN, and a 
client–server environment with data 
replication, providing a built-in disaster 
recovery system. The infrastructure 
supported changes in survey 
requirements as needed and was 
upgraded when necessary, for example, 
when new equipment was required for 
data collection or when security or other 
system requirements changed. 
ISIS used different computing 
platforms at different points in the data 
collection process. Tablet personal 
computers were used by interviewers to 
collect household interview data, and 
data were encrypted during all 
transmissions between the servers in the 
MEC trailers, the field office, contractor 
offices, and NHANES’ home office. 
Workstations and database servers were 
used for database access, data 
manipulation, review, and numerous 
other processes. Hardware and software 
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requirements changed and IT 
capabilities advanced. 
Data Collection and 
Processing 
NHANES data collection 
instruments were automated systems that 
integrated biomedical equipment, 
questionnaire items, and other data 
collection and administrative systems, to 
provide reliable and efficient electronic 
data capture. All instruments were tested 
for accuracy, calibration, and adherence 
to protocols. Data from these automated 
systems underwent stringent review to 
confirm the accuracy of the data and the 
data collection software, as well as 
compliance with data confidentiality 
requirements. All collected data were 
stored in an analytic database, and the 
data from all components were linked 
internally by a common identifier. 
Because NHANES’ reputation 
depends on maintenance of the 
confidentiality of all survey participants, 
all collected and stored NHANES data 
were protected with a high level of 
security, including encryption of the 
data. NHANES data were protected 
from loss through a system of regular 
automated backups and secure off-site 
storage, and NHANES maintained 
formal processes for disaster recovery 
and business continuity in compliance 
with federal regulations. 
Data Release 
At the conclusion of every 2-year 
cycle, NHANES data were released to 
the public. Data were edited to provide 
consistency and accuracy, and to 
preserve confidentiality. All direct 
personal identifiers, as well as any 
characteristics that could lead to 
identification, were omitted from the 
data sets. Data were reviewed by the 
NCHS Disclosure Review Board (DRB), 
and based on any recommendations 
from DRB, the data were then further 
edited. All data were released in a 
SAS-readable and -transportable format. 
Documentation describing edits to the 
data, and a codebook of data items, 
were provided for each component. All released data were available on the 
NHANES website. Some data items 
were not released publicly due to 
confidentiality or data quality issues. 
Data not released due to confidentiality 
restrictions were accessible via the 
NHCS Research Data Center (RDC) 
through a proposal process, and subject 
to availability and approval. For more 
information on NCHS RDC, visit 
http://www.cdc.gov/rdc/. 
Data Usability 
A standardized variable naming 
convention was developed to help 
researchers use the NHANES data sets. 
This naming convention consisted of 
each variable having an eight-character 
name, with defined positions having 
specific meanings. Positions 1 and 2 
represented the topic or subject. For 
example, the variable name for the urine 
pregnancy test was URXPREG. The 
‘‘UR’’ in positions 1 and 2 indicated 
that the variable concerns urine, and the 
‘‘X’’ in position 3 indicated that this is 
an examination variable. Other data 
types were indicated by other letters: 
Q = questionnaire, A = administrative, 
S = sampling, C = first random repeat 
quality-control items, G = gold standard 
quality-control repeat items, I = 
item-level components, and D = 
modified data items. For further 
information on how to analyze the data, 
visit http://www.cdc.gov/nchs/tutorials/. 
Conclusion 
This NHANES plan and operations 
1999–2010 report provides an overview 
of the conduct of NHANES in a single 
document. For more detailed 
information on NHANES, see the 
NHANES website at www.cdc.gov/ 
nhanes. Planning and implementing 
NHANES 1999–2010 involved 
numerous organizations and 
partnerships, and these collaborations 
were critical to the success of the 
survey. 
NHANES has been in operation for 
more than 50 years and collects 
high-quality health data. It is a unique 
survey in that it collects demographic, diet, medical, and behavioral data. It has 
remained responsive to new public 
health needs while maintaining the core 
measurements necessary for ongoing 
monitoring of our nation’s health. 
NHANES data have produced valuable 
tools, such as pediatric growth charts, 
which provide information on growth of 
infants and children. NHANES data 
have also supported national health 
initiatives and have been used to assist 
in policy decisions. NHANES continues 
to provide data on public health thanks 
to the thousands of Americans who 
participate each year. 
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Aliquoting—Dividing the blood into 
equal parts over several vials. 
Centrifugation—The process of 
putting biological samples into an 
instrument that spins around a central 
axis to separate materials into different 
layers with centrifugal force. All work 
was performed under the laminar-flow 
biological safety cabinet, using only 
those materials that the Centers for 
Disease Control and Prevention had 
prescreened for possible contamination. 
Ethics Review Board—In 2003, the 
National Health and Nutrition 
Examination Survey (NHANES) 
Institutional Review Board changed its 
name to the National Center for Health 
Statistics (NCHS) Research Ethics 
Review Board. 
Group quarters—A place where 
people live or stay that is normally 
owned or managed by an entity or 
organization providing housing or 
services for the residents. These services 
may include custodial or medical care, 
as well as other types of assistance, and 
residency is commonly restricted to 
those receiving these services. People 
living in group quarters are usually not 
related to each other. Group quarters 
include such places as college residence 
halls, residential treatment centers, 
skilled nursing facilities, group homes, 
military barracks, correctional facilities, 
workers’ dormitories, and facilities for 
people experiencing homelessness. 
These are generally grouped into two 
categories: institutional group quarters 
and noninstitutional group quarters. 
Institutional group quarters—Group 
quarters providing formally 
authorized, supervised care or 
custody in institutional settings, 
such as correctional facilities; 
nursing and skilled nursing 
facilities; inpatient hospice facilities; 
mental facilities (psychiatric 
hospital); group homes for 
juveniles; and residential treatment 
centers for juveniles. Institutional 
group quarters are not included in 
the NHANES sample. (For group 
quarters included in NHANES, see Noninstitutional group quarters.) 
Noninstitutional group quarters— 
Group quarters that do not provide 
formally authorized, supervised care 
or custody in institutional settings. 
These include college or university 
housing, group homes intended for 
adults, residential treatment 
facilities for adults, workers’ group 
living quarters, Job Corps centers, 
and religious group quarters. 
Noninstitutional group quarters are 
included in the NHANES sample. 
Household—The person or group of 
persons living in an occupied dwelling 
unit. 
Low income—Beginning in 2000, 
NHANES split the sampling domains 
for white persons and others based on 
their income status: low income or 
non-low income. Low-income persons 
are those at or below 130% of the 
federal poverty level. The poverty 
threshold used in this determination was 
based on the most recent poverty 
guidelines published by the U.S. 
Department of Health and Human 
Services; these thresholds are updated 
annually by the U.S. Census Bureau. 
National Center for Health 
Statistics (NCHS)—As the nation’s 
principal health statistics agency, NCHS 
designs, develops, and maintains a 
number of systems that produce data 
related to demographic and health 
concerns. These include data on 
registered births and deaths collected 
through the National Vital Statistics 
System, and data collected by the 
National Health Interview Survey, 
NHANES, the National Health Care 
Surveys, and the National Survey of 
Family Growth, among others. NCHS is 
part of the Centers for Disease Control 
and Prevention, an operating division of 
the U.S. Department of Health and 
Human Services (HHS). 
National Office of Vital Statistics— 
Part of the U.S. Public Health Service 
since transferring from the U.S. Bureau 
of the Census in 1946, the National 
Office of Vital Statistics was responsible for producing national vital statistics on 
births, deaths, fetal deaths, marriages, 
and divorces. In 1960, HHS merged this 
office with the National Health Survey 
program to form NCHS. 
Noninstitutionalized civilian 
population—Includes all people living 
in households and excludes those 
persons in institutional group quarters 
and those on active duty with the 
military. This is the target population for 
NHANES. 
Occupational Safety and Health 
Administration (OSHA)—The main 
federal agency charged with enforcing 
safety and health legislation. OSHA 
promulgated two standards relating to 
the safe use of chemicals in the 
workplace: ‘‘Hazard Communication’’ 
(29 CFR 1910.1200) and ‘‘Occupational 
Exposure to Hazardous Chemicals in 
Laboratories’’ (29 CFR 1910.1450). For 
more information on these standards, 
visit http://www.osha.gov/law-regs.html. 
Primary sampling unit (PSU)—The 
first-stage selection unit in a multistage 
area probability sample. In NHANES, 
PSUs are counties or groups of counties 
in the United States. Some PSUs are so 
large that they are selected into the 
survey with a probability of one. These 
are referred to as PSUs selected with 
certainty (‘‘certainty PSUs’’); all other 
PSUs are selected without certainty 
(‘‘noncertainty PSUs’’). 
Sample weight—The estimated 
number of persons in the target 
population that an NHANES respondent 
represents. For example, if a man in the 
sample represents 12,000 men in his 
race and ethnicity-income-age category, 
then his sample weight is 12,000. The 
NHANES sample weights were adjusted 
for different sampling rates (of the race 
and ethnicity-income-age-sex groups), 
different response rates, and different 
coverage rates among persons in the 
sample, so that accurate national 
estimates can be made from the sample. 
The product of all of these adjustments 
is sometimes called the ‘‘final’’ sample 
weight. 
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short) containing a set of questions 
asked of a household member to 
determine whether the household 
contains anyone eligible for the survey. 
In NHANES, the screener consisted of 
compiling a household roster and 
collecting the income level of the 
household and the race and ethnicity, 
age, and sex of all household members. 
In NHANES, only persons aged 18 and 
over can answer the screener. 
Screening—The process of 
conducting, or attempting to conduct, 
the screening interview in the selected 
dwelling units. Occupied dwelling units 
(households) are screened through the 
screening interview. Other units can also 
be screened; the process for these units 
is simply verification that they are 
vacant or that they are not dwelling 
units. See Screener. 
Segment—A group of housing units 
located near one another, all of which 
were considered for selection into the 
sample. For NHANES, segments consist 
of a census block, or groups of blocks, 
and their selection makes up the second 
stage of sampling for NHANES. Within 
each segment, a sample of dwelling 
units was selected. 
Weight—See Sample weight. 
Vital and Health Statistics 
Series Descriptions 
ACTIVE SERIES 
Series 1.	 Programs and Collection Procedures—This type of report 
describes the data collection programs of the National Center 
for Health Statistics. Series 1 includes descriptions of the 
methods used to collect and process the data, definitions, and 
other material necessary for understanding the data. 
Series 2.	 Data Evaluation and Methods Research—This type of 
report concerns statistical methods and includes analytical 
techniques, objective evaluations of reliability of collected 
data, and contributions to statistical theory. Also included are 
experimental tests of new survey methods, comparisons of 
U.S. methodologies with those of other countries, and as of 
2009, studies of cognition and survey measurement, and final 
reports of major committees concerning vital and health 
statistics measurement and methods. 
Series 3.	 Analytical and Epidemiological Studies—This type of  
report presents analytical or interpretive studies based on vital 
and health statistics. As of 2009, Series 3 also includes 
studies based on surveys that are not part of continuing data 
systems of the National Center for Health Statistics and 
international vital and health statistics reports. 
Series 10.	 Data From the National Health Interview Survey—This 
type of report contains statistics on illness; unintentional 
injuries; disability; use of hospital, medical, and other health 
services; and a wide range of special current health topics 
covering many aspects of health behaviors, health status, and 
health care utilization. Series 10 is based on data collected in 
this continuing national household interview survey. 
Series 11.	 Data From the National Health Examination Survey, the 
National Health and Nutrition Examination Surveys, and 
the Hispanic Health and Nutrition Examination Survey— 
In this type of report, data from direct examination, testing, 
and measurement on representative samples of the civilian 
noninstitutionalized population provide the basis for (1) 
medically defined total prevalence of specific diseases or 
conditions in the United States and the distributions of the 
population with respect to physical, physiological, and 
psychological characteristics, and (2) analyses of trends and 
relationships among various measurements and between 
survey periods. 
Series 13.	 Data From the National Health Care Survey—This type of 
report contains statistics on health resources and the public’s 
use of health care resources including ambulatory, hospital, 
and long-term care services based on data collected directly 
from health care providers and provider records. 
Series 20.	 Data on Mortality—This type of report contains statistics on 
mortality that are not included in regular, annual, or monthly 
reports. Special analyses by cause of death, age, other 
demographic variables, and geographic and trend analyses 
are included. 
Series 21.	 Data on Natality, Marriage, and Divorce—This type of 
report contains statistics on natality, marriage, and divorce 
that are not included in regular, annual, or monthly reports. 
Special analyses by health and demographic variables and 
geographic and trend analyses are included. 
Series 23.	 Data From the National Survey of Family Growth—These 
reports contain statistics on factors that affect birth rates, 
including contraception and infertility; factors affecting the 
formation and dissolution of families, including cohabitation, 
marriage, divorce, and remarriage; and behavior related to 
the risk of HIV and other sexually transmitted diseases. 
These statistics are based on national surveys of women and 
men of childbearing age. 
DISCONTINUED SERIES 
Series 4.	 Documents and Committee Reports—These are final 
reports of major committees concerned with vital and health 
statistics and documents. The last Series 4 report was 
published in 2002. As of 2009, this type of report is included 
in Series 2 or another appropriate series, depending on the 
report topic. 
Series 5.	 International Vital and Health Statistics Reports—This 
type of report compares U.S. vital and health statistics with 
those of other countries or presents other international data of 
relevance to the health statistics system of the United States. 
The last Series 5 report was published in 2003. As of 2009, 
this type of report is included in Series 3 or another series, 
depending on the report topic. 
Series 6.	 Cognition and Survey Measurement—This type of report 
uses methods of cognitive science to design, evaluate, and 
test survey instruments. The last Series 6 report was 
published in 1999. As of 2009, this type of report is included 
in Series 2. 
Series 12.	 Data From the Institutionalized Population Surveys— 
The last Series 12 report was published in 1974. Reports 
from these surveys are included in Series 13. 
Series 14.	 Data on Health Resources: Manpower and Facilities— 
The last Series 14 report was published in 1989. Reports on 
health resources are included in Series 13. 
Series 15.	 Data From Special Surveys—This type of report contains 
statistics on health and health-related topics collected in 
special surveys that are not part of the continuing data 
systems of the National Center for Health Statistics. The last 
Series 15 report was published in 2002. As of 2009, reports 
based on these surveys are included in Series 3. 
Series 16.	 Compilations of Advance Data From Vital and Health 
Statistics—The last Series 16 report was published in 1996. 
All reports are available online, and so compilations of 
Advance Data reports are no longer needed. 
Series 22.	 Data From the National Mortality and Natality Surveys— 
The last Series 22 report was published in 1973. Reports 
from these sample surveys, based on vital records, are 
published in Series 20 or 21. 
Series 24.	 Compilations of Data on Natality, Mortality, Marriage, and 
Divorce—The last Series 24 report was published in 1996. 
All reports are available online, and so compilations of reports 
are no longer needed. 
For answers to questions about this report or for a list of reports published 
in these series, contact: 
Information Dissemination Staff
 
National Center for Health Statistics
 
Centers for Disease Control and Prevention
 
3311 Toledo Road, Room 5419
 
Hyattsville, MD 20782
 
Tel: 1–800–CDC–INFO (1–800–232–4636)
 
TTY: 1–888–232–6348
 
Internet: http://www.cdc.gov/nchs
 
Online request form: http://www.cdc.gov/cdc-info/
 
requestform.html 
For e-mail updates on NCHS publication releases, subscribe 
online at: http://www.cdc.gov/nchs/govdelivery.htm. 
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